DrugName,DrugID,PubChemID,Target,Disease,Side_effect,NewDirectTarget,NewIndirectTarget,NewDisease,Evidence,Insilico,Invitro,Invivo,Clinicaltrial,SupportedSentences,PMID
Spiramycin,DB06145,6440717,Gram-positive bacteria,Bacterial infection,,,LPS; iNOS; MAPKs; ERK; JNK; NF-?oB,Anti-inflammatory,Human skin primary irritation tests,,Human skin primary irritation tests,,,Anti-Inflammatory Effects of Spiramycin in LPS-Activated RAW 264.7 Macrophages,35630676
Disulfiram,DB00822,3117,AL3A2,Alcohol dependence,,,metastasis related proteins (PCNA; MMP-2); Wnt and NF-?oB pathways (MKN-45; SGC-7901),Gastric cancer,Transwell assays; ELISA,,Transwell assays; ELISA,,,The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-?oB pathways,32529870
Fluvoxamine,DB00176,3404,Serotonin system,Depression,,,A?242,Alzheimer's disease (AD),Aggregation kinetic experiments; transmission electron microscopy experiments; dot-blot study,,Aggregation kinetic experiments; Transmission electron microscopy experiments; Dot blot study,,,These studies demonstrate that SSRIs have the potential to prevent A?242 aggregation by direct binding preventing A?242 aggregation and fibrillogenesis and could be beneficial to AD patients on SSRIs.,30157623
Paroxetine,DB00715,43815,SC6A4,Depression,,,A?242,Alzheimer's disease (AD),Aggregation kinetic experiments; transmission electron microscopy experiments; dot-blot study,,Aggregation kinetic experiments; Transmission electron microscopy experiments; Dot blot study,,,These studies demonstrate that SSRIs have the potential to prevent A?242 aggregation by direct binding preventing A?242 aggregation and fibrillogenesis and could be beneficial to AD patients on SSRIs.,30157623
Fluoxetine,DB00472,3386,SC6A4,Depression,,,A?242,Alzheimer's disease (AD),Aggregation kinetic experiments; transmission electron microscopy experiments; dot-blot study,,Aggregation kinetic experiments; Transmission electron microscopy experiments; Dot blot study,,,These studies demonstrate that SSRIs have the potential to prevent A?242 aggregation by direct binding preventing A?242 aggregation and fibrillogenesis and could be beneficial to AD patients on SSRIs.,30157623
Sertraline,DB01104,68617,SC6A4,Depression,,,A?242,Alzheimer's disease (AD),Aggregation kinetic experiments; transmission electron microscopy experiments; dot-blot study,,Aggregation kinetic experiments; Transmission electron microscopy experiments; Dot blot study,,,These studies demonstrate that SSRIs have the potential to prevent A?242 aggregation by direct binding preventing A?242 aggregation and fibrillogenesis and could be beneficial to AD patients on SSRIs.,30157623
Escitalopram,DB01175,146570,SC6A4,Depression,,,A?242,Alzheimer's disease (AD),Aggregation kinetic experiments; transmission electron microscopy experiments; dot-blot study,,Aggregation kinetic experiments; Transmission electron microscopy experiments; Dot blot study,,,These studies demonstrate that SSRIs have the potential to prevent A?242 aggregation by direct binding preventing A?242 aggregation and fibrillogenesis and could be beneficial to AD patients on SSRIs.,30157623
Sildenafil,DB00203,5212,PDE5,Erectile dysfunction; Coronavirus Disease 2019 (COVID-19),,,CYP3A4,Lung cancer,in vitro experiments; Mouse modeling,,Cytotoxicity assay; Reactive oxygen species (ROS) production,Mouse modeling,,"Sildenafil has also been proven as an agent to decrease drug-efflux by cancer cells and increases blood perfusion to lung tissue, which can potentially increase the dosage of chemotherapeutic agents delivered to lung cancer cells compared to healthy tissue.",29110626
Tamoxifen,DB00675,2733526,ESR1,Breast cancer,,,NRF2,Immune-mediated diseases,PCR; Western blot; Luciferase assay; ELISA; Cell viability Assays,,RT-qPCR; Western blot; Luciferase assay; ELISA; Cell viability assays,,,"In summary, our study demonstrates that pharmacological concentrations of TAM act in macrophages independently of ER?¡À and are able to skew macrophage polarizationinduced by inflammatory conditions. These results provide novel hypothesis for TAM pharmacology in breast cancer and other off-target clinical indications and provide molecular targets for future drug development strategies.",34653752
Nitazoxanide,DB00507,41684,PNO,Diarrhea,,,HCT116 GFP cell,Quiescent and glucose-deprived clonogenic colon tumour cells,Monolayer experiments; spheroid experiments; clonogenic assay,,Monolayer experiments; Spheroid experiments; Clonogenic assay,,,Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells,35261637
AZD-7762,DB12242,11152667,CHK1,Solid tumour/cancer,,,Lyn; Fyn,Degranulation of mast cells and allergic response,in vitro protein kinase assay; experiments with mast cells in vitro; mouse modeling,,Protein kinase assay; Experiments with mast cells,Mouse modeling,,"Now, we demonstrate for the first time that AZD7762 effectively suppresses the degranulation of mast cells and allergic response in vivo via the inhibition of Lyn and Fyn in mast cells.",29777684
Simeprevir,DB06290,24873435,POLG,Chronic HCV-1 infection,,,cell membranes,MRSA,"membrane permeability assay, membrane potential assay, intracellular ATP level assay, and electron microscope observation; mouse modeling",,Membrane permeability assay; Membrane potential assay; Intracellular ATP level assay; Electron microscope observation,Mouse modeling,,Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA,35338386
Ivermectin,DB00602,46936176,GABA,Onchocerciasis,,,Th1-type,Tegumentary leishmaniasis,In vitro experiments; immunological parasitological and biochemical evaluations,,Immunological parasitological; Biochemical evaluations,,,Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis,36774730
Butenafine,DB01091,2484,ERG1,Dermatologic infection,,,enzyme squalene epoxidase,Visceral Leishmaniasis,Solubility Studies; Pseudo-Ternary Phase Diagrams; Angle of Repose (AoR) Measurements; Particle Size Measurements; ANOVA test,,Solubility studies; Pseudo ternary phase diagrams; AoR measurements; Particle size measurements,,,Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis,31330776
Masitinib,DB11526,10074640,SRC,Amyotrophic lateral sclerosis; Metastatic gastric or gastroesophageal junction cancer; Multiple sclerosis; Gastrointestinal stromal tumour; Ovarian cancer; Pancreatic cancer,,,Organic Cation Transporters,COVID-19,Fluorescence Measurements; HPLC; Statistical Analysis,,Fluorescence measurements; HPLC; Statistical analysis,,,"Interaction of Masitinib with Organic Cation Transporters; Tyrosine kinase inhibitors (TKI) such as Masitinib were reported to be useful as therapeutic options in malignant disorders and nonmalignant diseases, like coronavirus disease 2019 (COVID-19).",36430667
Levocetirizine,DB06282,1549000,transmembrane G protein-coupled receptors; histamine H1 receptors,"Cutaneous, respiratory, and ocular allergies",,,prostaglandin,Alopecia,modified ethanol injection method; Studenta€?s t-test; Transmission electron microscopy (TEM); Explicit molecular dynamics simulation; Histopathologic evaluation,Molecular dynamics simulation,Modified ethanol injection method; TEM; Histopathologic evaluation,,,"Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, in- silico and in-vivo studies",36047012
Methylene blue,DB09241,6099,redox indicator,Acquired methemoglobinemia,,,SIRT1; AMPK; CPT-1; PPAR?¡À,Nonalcoholic fatty liver disease; steatosis and steatohepatitis,Immunoblotting PCR and reporter assays,,Immunoblotting PCR;  Reporter assays,,,"SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis",24486702
Trimipramine,DB00726,5584,SC6A2,Depression,,,Autocrine survival signals involving neurotransmitters and their G protein-coupled receptors,Small cell lung cancer (SCLC),MTT Assays and Calcium Measurement; Immunoblot Analysis and Immunostaining; fluorescent analysis; Student t test,,MTT assays; Calcium measurement; Immunoblot analysis; Immunostaining; Fluorescent analysis,,,A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors,24078773
Raloxifene,DB00481,5035,ESR1,Osteoporosis,,,HepG2 and HuH7 cells,Liver Cancer,3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide (MTT) colorimetric method; Annexin V-FITC kit (Thermo Fisher Scientific Waltham MA USA); Colony formation assay; One-way ANOVA analysis; Tukeya€?s test,,MTT colorimetric method; Annexin V-FITC kit; Colony formation assay,,,The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer,37103074
Loratadine,DB00455,3957,HRH1,Allergy; Allergic rhinitis,,,HepG2 and HuH7 cells,Liver Cancer,3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide (MTT) colorimetric method; Annexin V-FITC kit (Thermo Fisher Scientific Waltham MA USA); Colony formation assay; One-way ANOVA analysis; Tukeya€?s test,,MTT colorimetric method; Annexin V-FITC kit; Colony formation assay,,,The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer,37103074
Batimastat,DB03880,5362422,MMP3,Idiopathic pulmonary fibrosis; Tissue repair disorder; Tumor development; Inflammatory disorder,,,Group I (PI) metalloprotease (CAMP-2),"Venom of the western diamondback rattlesnake, Crotalus atrox",Mass Spectrometry Analysis; Fluorogenic Assays; Fibrinogenolytic Assay; Aggregation Assay; Haemolytic Assay; LDH Cytotoxicity Assay,,Mass spectrometry analysis; Fluorogenic assays; Fibrinogenolytic assay; Aggregation assay; Haemolytic assay; LDH cytotoxicity assay,,,"Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox",32397419
Marimastat,DB00786,119031,MMP1; MMP2; MMP7,Pancreatic cancer; Lung cancer; Tissue repair disorder; Tumor development; Inflammatory disorder,,,Group I (PI) metalloprotease (CAMP-2),"Venom of the western diamondback rattlesnake, Crotalus atrox",Mass Spectrometry Analysis; Fluorogenic Assays; Fibrinogenolytic Assay; Aggregation Assay; Haemolytic Assay; LDH Cytotoxicity Assay,,Mass spectrometry analysis; Fluorogenic assays; Fibrinogenolytic assay; Aggregation assay; Haemolytic assay; LDH cytotoxicity assay,,,"Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox",32397419
Praziquantel,DB01058,4891,HPGDS,Schistosomiasis,,,STAT3,Psoriasis,Mouse modeling,,,Mouse modeling,,The anthelmintic drug praziquantel has been used as a standard treatment for schistosomiasis for over 40 years. This study aimed to repurpose praziquantel to treat psoriasis.,34363611
Dexamethasone,DB01234,5743,GCR,Coronavirus Disease 2019 (COVID-19),,,PPAR-?3,Dedifferentiated liposarcoma,Adipogenic differentiation assay; in vivo xenograft models,,Adipogenic differentiation assay,Xenograft,,This study suggests a potential application of drug repositioning in which adipogenesis-inducing compounds could be used to treat DDLPS patients in a clinical setting.,31069877
Indomethacin,DB00328,3715,PGH2,Rheumatoid arthritis,,,PPAR-?3,Dedifferentiated liposarcoma,Adipogenic differentiation assay; in vivo xenograft models,,Adipogenic differentiation assay,Xenograft,,This study suggests a potential application of drug repositioning in which adipogenesis-inducing compounds could be used to treat DDLPS patients in a clinical setting.,31069877
Insulin human,DB00030,118984375,insulin receptors,Diabetic complication,,,PPAR-?3,Dedifferentiated liposarcoma,Adipogenic differentiation assay; in vivo xenograft models,,Adipogenic differentiation assay,Xenograft,,This study suggests a potential application of drug repositioning in which adipogenesis-inducing compounds could be used to treat DDLPS patients in a clinical setting.,31069877
3-isobutyl-1-methyl-7H-xanthine,DB07954,3758,AA2BR; PDE4B; PDE4D; PDE5A; PDE4A; AA2AR; AA1R; AA3R; PDE2A; PDE3A,Chronic obstructive pulmonary disease; Bronchial Asthma,,,PPAR-?3,Dedifferentiated liposarcoma,Adipogenic differentiation assay; in vivo xenograft models,,Adipogenic differentiation assay,Xenograft,,This study suggests a potential application of drug repositioning in which adipogenesis-inducing compounds could be used to treat DDLPS patients in a clinical setting.,31069877
Novobiocin,DB01051,54675769,TOP2A; TOP2B,Bacterial infection,,,Chikungunya nsP2 protease,Chikungunya,SPR experiments; small angle x-ray scattering; Protease activity measurement; plaque formation assays,,SPR experiments; Small angle x-ray scattering; Protease activity measurement; Plaque formation assays,,,"We utilized an in-silico drug screening with FDA approved molecule library to identify inhibitors of the chikungunya nsP2 protease, a multifunctional and essential non-structural protein required for virus replication. Telmisartan, an anti-hypertension drug, and the antibiotic novobiocin emerged among top hits on the screen.",32791353
Telmisartan,DB00966,65999,AGTR1,Hypertension,,,Chikungunya nsP2 protease,Chikungunya,SPR experiments; small angle x-ray scattering; Protease activity measurement; plaque formation assays,,SPR experiments; Small angle x-ray scattering; Protease activity measurement; Plaque formation assays,,,"We utilized an in-silico drug screening with FDA approved molecule library to identify inhibitors of the chikungunya nsP2 protease, a multifunctional and essential non-structural protein required for virus replication. Telmisartan, an anti-hypertension drug, and the antibiotic novobiocin emerged among top hits on the screen.",32791353
Eltrombopag,DB06210,9846180,thrombopoietin receptor (c-Mpl receptor),Chronic Liver Thrombocytopenia; Idiopathic thrombocytopenic purpura,,,The transmembrane spike (S) glycoprotein,SARS-CoV-2,Homology Modeling; Surface plasmon resonance; Virtual drug design; in vitro molecular interaction experiments,,Homology modeling; Surface plasmon resonance; Molecular interaction experiments,,,Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein,32540428
Linagliptin,DB08882,10096344,DPP4,Type-2 diabetes,,,Rb; Pro-caspase3; Bcl-2,Colorectal cancer,Western blot; Gene regulatory network,Gene regulatory network,Western blot,,,"Hypoglycemic drug linagliptin could potentially lead to novel therapeutics for the treatment of tumors, especially for colorectal cancer.",32194417
Amodiaquine,DB00613,2165,HNMT,Malaria,,,Papain-like protease,SARS-CoV-2,structural analysis; molecular docking; molecular dynamics simulations; in vitro experiment,Molecular docking; Molecular dynamics simulations,Structural analysis,,,"Virtual screening highlighted amodiaquine and methylene blue as the best candidates, and these findings were complemented by the in vitro results that indicated amodiaquine as a ??M PLpro deubiquitinase inhibitor.",36453012
Methylene blue,DB09241,6099,methemoglobin,Acquired methemoglobinemia,,,Papain-like protease,SARS-CoV-2,structural analysis; molecular docking; molecular dynamics simulations; in vitro experiment,Molecular docking; Molecular dynamics simulations,Structural analysis,,,"Virtual screening highlighted amodiaquine and methylene blue as the best candidates, and these findings were complemented by the in vitro results that indicated amodiaquine as a ??M PLpro deubiquitinase inhibitor.",36453012
Micafungin,DB01141,477468,FKS2,Candidiasis,,,EV71,Hand-foot-mouth disease (HFMD); severe neurological complications,in vitro-transcribed EV71-replicon RNAs; assayed for firefly luciferase activity,,RNA transcription; Firefly luciferase activity,,,"We identified micafungin, an echinocandin antifungal drug, as a novel inhibitor of EV71. Micafungin potently inhibits the proliferation of EV71 as well as the replication of EV71 replicon in cells with a low micromolar IC50 (~5 ??M).",27296985
Eltrombopag,DB06210,9846180,thrombopoietin receptor (c-Mpl receptor),Thrombocytopenia; Idiopathic thrombocytopenic purpura,,,Late Processes of the Replication Cycle (Fe3+ chelation),HCMV,Virus Infectivity Assay; Viability Assay; Virus Yield Assay; Immunoblotting,,Virus infectivity assay; Viability assay; Virus yield assay; Immunoblotting,,,Therapeutic eltrombopag concentrations inhibit HCMV replication via chelation of Fe3+ ions. Eltrombopag is effective against drug-resistant viruses and synergistically increases the effects of the mainstay anti-HCMV drug ganciclovir.,31861948
Ketotifen,DB00920,3827,HRH1,Allergic conjunctivitis; Allergic rhinitis; Bronchial asthma,,,IL-6/STAT3 pathway,Neuroendocrine prostate cancer,Drug screening; RT-qPCR; Western blot; Celltiter-Glo; Flow cytometry; Colony formation assay; Wound healing assay; Transwell assay; RNA sequencing; H&E; IHC; ELISA,Virtual screening,RT-qPCR; RNA sequencing; Western blot; Celltiter-Glo; Flow cytometry; Colony formation assay; Wound healing assay; Transwell assay; H&E; IHC; ELISA,,,Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway,37120492
Repaglinide,DB00912,65981,ABCC8; ABCC9,Diabetic complication,,,Bcl-2; Beclin-1; PD-L1,Glioblastoma multiforme,In vitro experiments,,Cell viability assay; Cell migration assay,Mouse modeling,,"Drug repositioning in Connectivity Map by using the gene expression signature identified repaglinide, a first-line drug for diabetes mellitus, as the most promising novel drug for GBM.",28476618
Tamoxifen,DB00675,2733526,ESR1,Breast cancer,,,Although TAM-estrogen receptor interaction is well recognized; we still do not understand its entire mechanism of action.,Schistosomiasis,in vivo experiments,,Schistosomicidal assays,Mouse modeling,,"Repurposing anti-cancer and antibacterial drugs against several helminthic infections has been trialed, due to reduced costs and ethical reasons (Cowan and Keiser 2015; Panic et al. 2014). One of these drugs is tamoxifen (TAM), an anti-cancer drug widely used to treat and prevent breast cancer as it works as a selective estrogen receptor modulator (Bhattacharya et al. 2017).",30798369
Zidovudine,DB00495,35370,FLT3; POL,Human immunodeficiency virus infection,,,Cellular kinases,Carbapenem-resistant Enterobacteriaceae (CRE),Minimum inhibitory concentration (MIC) determination assay; Bactericidal/static determination assay; Time-kill assay,,MIC determination assay; Bactericidal/static determination assay; Time-kill assay,,,Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections,29019016
Tigecycline,DB00560,54686904,F4NA87,Skin infection,,,Bacterial ribosome,Carbapenem-resistant Enterobacteriaceae (CRE),Minimum inhibitory concentration (MIC) determination assay; Bactericidal/static determination assay; Time-kill assay,,MIC determination assay; Bactericidal/static determination assay; Time-kill assay,,,Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections,29019016
Irbesartan,DB01029,3749,AGTR1,Hypertension,,,Na(+)-dependent taurocholate cotransporting polypeptide,HBV,transcription activator-like effector nucleases (TALEN) technology,,TALEN technology,,,"Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity",26086883
Eltrombopag,DB06210,9846180,thrombopoietin receptor (c-Mpl receptor),Thrombocytopenia; Idiopathic thrombocytopenic purpura,,,Virulence factors and the calcineurin pathway,Cryptococcosis,fractional inhibitory concentration index (FICI); RNA sequencing; deletion mutant library screening experiments,,FICI; RNA sequencing; deletion mutant library screening experiments,,,"In conclusion, eltrombopag exhibited excellent antifungal activity against Cryptococcus species potentially via a mode of action which interferes with virulence factors and the calcineurin pathway, indicating that eltrombopag might be usefully repurposed as an antifungal agent for treating cryptococcosis.",31297540
Itraconazole,DB01167,55283,CP51,Fungal infection,,,CYP51,Visceral leishmaniasis,Cytotoxicity assay; Antiamastigote activity; Experimental animals and ethics statement,,Cytotoxicity assay; Antiamastigote activity,,Experimental animals,"The results demonstrate for the first time the activity of ezetimibe in a viscerotropic species of Leishmania and indicate that ternary treatment composed of miltefosine, itraconazole, and ezetimibe at low doses is a promising therapeutic alternative for the treatment of visceral leishmaniasis.",33619058
Ezetimibe,DB00973,150311,NPCL1,Hypercholesterolaemia,,,CYP51,Visceral leishmaniasis,Cytotoxicity assay; Antiamastigote activity; Experimental animals and ethics statement,,Cytotoxicity assay; Antiamastigote activity,,Experimental animals,"The results demonstrate for the first time the activity of ezetimibe in a viscerotropic species of Leishmania and indicate that ternary treatment composed of miltefosine, itraconazole, and ezetimibe at low doses is a promising therapeutic alternative for the treatment of visceral leishmaniasis.",33619058
Miltefosine,DB09031,3599,PA21B,Leishmaniasis; Visceral leishmaniasis,,,CYP51,Visceral leishmaniasis,Cytotoxicity assay; Antiamastigote activity; Experimental animals and ethics statement,,Cytotoxicity assay; Antiamastigote activity,,Experimental animals,"The results demonstrate for the first time the activity of ezetimibe in a viscerotropic species of Leishmania and indicate that ternary treatment composed of miltefosine, itraconazole, and ezetimibe at low doses is a promising therapeutic alternative for the treatment of visceral leishmaniasis.",33619058
Benserazide,DB12783,2327,DDC,Parkinson,,,Hexokinase 2 (HK2) (most closely related to malignant tumor),Tumor,In vitro enzyme inhibition assay; Microscale thermophoresis (MST) assay; Cytotoxicity test; Western blog,,Enzyme inhibition assay; MST assay; Cytotoxicity test; Western blot,,,"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2",28427443
Crizotinib,DB08865,11626560,MET; ALK; ROS1,Non-small-cell lung cancer,,,CTP Synthase PyrG,Gram-Positive Bacteria,determination of the MIC; Scanning electron microscopy analysis; RT-qPCR,,MIC; Scanning electron microscopy analysis; RT-qPCR,,,"In this study, we found that a repurposed drug, crizotinib, exhibits excellent antibacterial activity against drug-resistant bacteria both in vivo and in vitro via suppressing ATP production and pyrimidine metabolism. Crizotinib was found to disturb pyrimidine metabolism by targeting the CTP synthase PyrG, thus reducing DNA synthesis. This unique mechanism of action may explain the decreased development of resistance by Staphylococcus aureus to crizotinib.",35674439
Nortriptyline,DB00540,4543,SC6A4,Bladder cancer; Depression,,,Caspase-3; annexin V,Multiple myeloma,Cell viability assays; Flow cytometry; Cell cycle analysis; Apoptosis assays; Statistical analysis,,Cell viability assays; Flow cytometry; Cell cycle analysis; Apoptosis assays,,,In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma,30930625
Amodiaquine,DB00613,2165,HNMT,Malaria,,,Caspase-3; LC3B-II,NSCLC,scratch assay; clonogenic assay,,Scratch assay; Clonogenic assay,,,Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC),32600728
Brefeldin A,DB07348,5287620,CRISPR/Cas9 activator; HSV-1,Anticancer; antiviral,,,cGAS; NLRP3,Inflammatory bowel disease,Anti-inflammatory Assay Mouse Model Validation of Drug Efficacy,,,Mouse modeling,,BFA inhibited inflammation through blocking cGAS expression and type I IFN response in colitis model and human colon cancer cells,34158863
Nintedanib,DB09079,9809715,Receptor Tyrosine Kinases (RTKs),Idiopathic pulmonary fibrosis; Coronavirus Disease 2019 (COVID-19),,Treg cells (CTLA-4 and PD-1 expressing CD4+ T cells),COL1A1; COL3A1; bFGF; bFGF,Heart Failure,qPCR; Cell migration assay; Western blot; flow cytometric analysis,,RT-qPCR; Cell migration assay; Western blot; flow cytometric analysis,,,"NTB treatment remarkably reduced cardiac fibrosis as confirmed by Massona€?s trichrome staining and decreased expression of collagen genes (COL1A1, COL3A1). NTB treatment inhibited TGF-?21-induced production of fibrogenic protein (?¡À-SMA and fibronectin). NTB treatment prevented bFGF induced ERK and AKT activation in cardiac fibroblasts. our in vitro experiments demonstrated that NTB treatment leads to induction of immunosuppressive phenotype in Treg cells;",33965510
Rilpivirine,DB08864,6451164,POL; SCNAA,Human immunodeficiency virus infection,,,Adipor1; Pnpla3; Lepr; NF-?oB and Casp1; Il-6; STAT3; STAT1,Chronic liver injury,western blot; RT-PCR; Myeloperoxidase activity,,Western blot; RT-PCR; Myeloperoxidase activity,,,"RPV altered theexpression of several genes involved in lipid metabolism, upregulating the antisteatotic genes Adipor1 and Pnpla3 and decreasing the expression of the pro-steatotic gene Lepr. RPV also exerted anti-inflammatory actions, significantly diminishing MPO activity, NF-?oB and Casp1 activation.RPV enhanced STAT3-dependent proliferation in hepatocytes and apoptosis in HSC through selective STAT1 activation in mice; RPV undermined STAT3 activation and triggered STAT1-mediated pathways and apoptosis in HSC",31530714
Naltrexone,DB00704,5360515,opioid receptors,Chronic alcoholism; Coronavirus Disease 2019 (COVID-19),,Toll-like receptor 4,iNOS; CD206; p70S6K,Inflammatory,Immunofluorescence; Western blot,,Immunofluorescence; Western blot,,,"Naltrexone in low doses ranging from 1 to 5 mg, acts as a glial modulator by specifically binding to Toll-like receptor 4 (TLR-4) as an antagonist. LDN induced a shift from highly activated pro-inflammatory phenotype (iNOShighCD206low) to quiescent anti-inflammatory M2 phenotype (iNOSlowCD206high) in BV-2 microglia cells. dministration of LDN increases total protein expression of p70S6K in a dose dependent manner.",34445130
Promethazine,DB01069,4927,HRH1,Nausea,,,Bcl-2; Bax; caspase-3; PI3K/Akt signaling pathway,Colorectal cancer,Cell viability assay; Colony formation assay; Apoptosis assay; Western blot,,Cell viability assay; Colony formation assay; Apoptosis assay; Western blot,,,"PMTZ induces the apoptosis of CRC cells by altering the expression of Bcl-2, Bax, and caspase-3.PMTZ exerted a dose-dependent inhibitory effect on the PI3K/AKT signaling pathway in CRC cells.",34560542
Azelastine,DB00972,2267,HRH1,Allergic conjunctivitis,,ARF1,Bcl-xL; Bcl-2; p-Drp1; p-ERK,Colorectal cancer,Mass spectrometry; Drug Affinity Responsive Target Stability (DARTS) assay; Biacore assay; Tumor xenograft,,Mass spectrometry; DARTS assay; Biacore assay; Tumor xenograft,,,"Azelastine, a current anti-allergic drug, was found to exert a significant inhibitory effect on CRC cell proliferation in vitro and in vivo, but not on ARF1-deficient or ARF1-T48S mutant cells. ARF1 knockout significantly attenuated the inhibitory effect of azelastine on CRC cell proliferation. Decreased expression levels of Bcl-xL and Bcl-2 proteins involved in the mitochondrial pathway of azelastine-treated CRC cells. Azelastine significantly decreased the expression of p-Drp1. p-ERK expression was significantly decreased in azelastine-treated CRC cells.",33408784
Metformin,DB00331,4091,ACACB; S47A1,Type-2 diabetes,,,GST; SOD; CAT; GPx and GR; AST; ALT; ALP; ?3 GT and XO; PC; AOPP; TNF-?¡À and HP,Liver tissue damage associated with prostate cancer and diabetes,ELISA; spectrophotometrically inform,,ELISA; Spectrophotometrically inform,,,"Administration of metformin to DC group decreased GST activities in a very significant manner (p < 0.0001). More so, SOD, CAT, GPx and GR activities decreased in a significant manner (p < 0.05). Metformin reversed AST activities in a very significant manner (p < 0.0001), while ALT, ALP, ?3 GT and XO activities were significantly decreased. Administration of metformin reversed PC, AOPP, TNF-?¡À and HP levels in DC group in a significant manner (p < 0.0001, p < 0.05), respectively. Metformin also significantly decreased PC, TNF-?¡À and HP levels in cancer groups (p < 0.05; p < 0.0001), respectively.",37255805
Disulfiram,DB00822,3117,AL3A2,Alcohol dependence,,,NPL4,Multiple myeloma,Western blot; Immunofluorescence; flow cytometry,,Western blot; Immunofluorescence; Flow cytometry,,,"Instead, the DSFa€?s metabolite CuET represents the ultimate anticancer agent, explaining potentiation of DSF by copper. Treatment of cells with CuET evokes phenotypes resembling inhibitors of protein degradation such as bortezomib or p97 via inhibition and aggregation of NPL4, an essential co-factor of p97 segregase involved in protein degradation upstream of the proteasome.",35246527
Pimozide,DB01100,16362,DRD2,Schizophrenia,,,?2-hexosaminidase; SYK; p38; ERK; and JNK; IL-4 and IL-10,Immunoglobulin E (IgE)-mediated MC activation and MC-mediated allergic responses,Measurement of cell viability; Measurement of MC degranulation,,Measurement of cell viability; Measurement of MC degranulation,,,"Pimozide treatment reduced released levels of the granule-related mediator ?2-hexosaminidase dose-dependently in DNP-HAS-activated RBLs. Pimozide pretreatment attenuated the phosphorylation of SYK, p38, ERK, and JNK in activated RBLs. total serum IL-4 and IL-10 levels were increased after the OVA challenge and those increases were suppressed by pimozide.",32311669
Acetylcysteine amide,DB14480,10176265,glutathione,Acetaminophen toxicity,,,IFN-?¡À; IFN-?2; receptor IFNAR1; ALT and AST; caspase-3; JNK1/2; SOD; CAT; IRF-7; IFNA2; IFNB1 and IFNAR1,Dengue,Cell viability assay; RT-PCR; ELISA,,Cell viability assay; RT-PCR; ELISA,,,Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection,30928439
Caspofungin,DB00520,3035406,Fungal cell wall,Fungal infection,,Potent A?2,,Alzheimer's disease,Molecular docking; Thioflavin-T fluorescence kinetics,Molecular docking,Thioflavin-T fluorescence kinetics,,,"Caspofungin (CAS) is a potent A?2 aggregation inhibitor that displays significantly reduced toxicity associated with AD. Drug reprofiling and REMD simulations demonstrated that CAS interacts with the ?2-sheet section, known as A?2 amyloid fibrils hotspot.",33722677
Olaparib,DB09074,23725625,PARP,Ovarian cancer; Pancreatic cancer; Prostate cancer,,,TNF?¡À; IL-1?¡À; IL-1?2; IL-2; IL-4; IL-6; IL-12p40; miR15; miR17; miR181 and miR365; miR146; MIP1?¡À; M-CSF and MIG,Sepsis,Flow cytometry; RT-PCR;,,Flow cytometry; RT-PCR;,,,"Olaparib treatment in the CLP model attenuated the increases in the levels of several circulating mediators in the plasma (e.g. TNF?¡À, IL-1?¡À, IL-1?2, IL-2, IL-4, IL-6, IL-12p40). olaparib treatment attenuated the CLP-induced alterations in miR15, miR17, miR181 and miR365 and levels. For miR146, in the spleen, olaparib attenuated its CLP-induced downregulation, while in the circulating leukocytes, olaparib enhanced its CLP-induced upregulation. Circulating levels of the CLP-induced mediators TNF?¡À, IL-1?¡À, MIP1?¡À, M-CSF and MIG were significantly reduced by olaparib treatment.",31071432
Ponatinib,DB08901,24826799,RET; FLT3; KIT; ABL1; BCR,Acute lymphoblastic leukaemia; Chronic myeloid leukemia,,PD-L1,,Tumor,fluorescence quenching assay; immunofluorescence study,,Fluorescence quenching assay; Immunofluorescence study,,,"Ponatinib showed stable binding with PD-L1, with the highest binding energy among all of the screened FDA-approved drugs. The binding of Ponatinib with PD-L1 was supported by a fluorescence quenching assay and immunofluorescence study. Ponatinib also reduced the expression of PD-L1 in tumors and increased the T-cell population.",36798474
Quinacrine,DB01103,237,PA21B,Malarial,,,Annexin V; LC3B-1; LC3B-2; caspase-3,Malignant Pleural Mesothelioma,flow cytometry; Clonogenic Assay; Scratch Assay; Western blot,,Flow cytometry; Clonogenic assay; Scratch assay; Western blot,,,"As the concentration of QA increased (from 0.39 ??M to 0.78 ??M), levels of Annexin V significantly increased in a concentration dependent manner for both. The aforementioned induction of caspase-3 was evident after QA treatment concentrations. LC3B-1 is downregulated and LC3B-2 is upregulated (24-h treatment) as QA concentration is increased.",32878257
Fluvoxamine,DB00176,3404,Serotonin reuptake,Depression,,,Rheumatic factor; C-reactive proteins; SOD; CAT; TNF-?¡À; PGE2; IL-1?2;,Arthritic,ELISA,,ELISA,,,"Similarly, the high dose of fluvoxamine (50 mg/kg) significantly decreased the level of RF and CRP to level of 12.0?¡À0.707 and 11.40?¡À0.50 respectively. The expression of SOD and CAT in arthritic animals was 30.2?¡À1.06 and 28.0?¡À0.707 respectively. In treatment groups, fluvoxamine (25 and 50 mg/kg orally) restored the expression of SOD, CAT to 36.6?¡À1.2, 37.8?¡À0.8 and 69.8?¡À1.5, 72.0?¡À1.4 respectively. Inhibitory effect of fluvoxamine on gene expression of cytokines (TNF-?¡À, PGE2 and IL-1?2)",36152089
Fludarabine,DB01073,657237,ADA,Chronic lymphocytic leukaemia; Haematological malignancy,,,STAT1,Malignant pleural mesothelioma,Western blot; Immunofluorescence; Flow cytometry,,Western blot; Immunofluorescence; Flow cytometry,,,"We observed that F-araA could repress the expression of STAT1. F-araA could be therapeutically active against MPM cells, in addition to other tumour types, by inhibiting STAT1 expression and nucleic acids synthesis.",33300108
Maxacalcitol,DB06272,6398761,VDR,Psoriasis; Disorder of calcium metabolism,,,Tslp,Influenza vaccine,Immunization; Influenza infection study; ELISA; Flow cytometry; RNA-seq; Quantitative RTa€¡°PCR,,Immunization; ELISA; Flow cytometry; RNA-seq; Quantitative RTa€¡°PCR,Influenza infection study,,Repurposing the psoriasis drug Oxarol to anointment adjuvant for the influenza vaccine,32060507
Nifuroxazide,DB13855,5337997,Bacterial enzymes,Diarrhoea,,,TGF-?21; Stat3,Pulmonary fibrosis,ELISA; hydroxyproline content; H&E and Masson staining; immunohistochemistry (IHC); Western blot,,ELISA; Hydroxyproline content; H&E and masson staining; Immunohistochemistry; Western blot,,,Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study,35172837
Lvermectin,DB00602,,Glutamate-gated chloride channels in parasites,Parasitic infestations,,,IMP?¡À/?21; STAT3,Covid-19,MD simulations; molecular biology experiments,MD simulations,Molecular biology experiments,,,Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication,34687900
Parbendazole,,26596,Microtubules in parasites,Anthelmintic drug,,Tubulin,,Head and neck squamous cell carcinoma,Cell proliferation/survival assay; Xenograft tumor assay on mice; Xenograft tumor assay on zebrafish; Acute toxicity test; Cell apoptosis assay; Cell cycle assay; Western blot; Cell migration assay; Tubulin polymerization assay; Immunofluorescence assay; qPCR assay,,Cell proliferation assay; Acute toxicity test; Cell apoptosis assay; Cell cycle assay; Western blot; Cell migration assay; Tubulin polymerization assay; Immunofluorescence assay; PT-qPCR,Mouse xenograft; Zebrafish xenograft,,"Our study repositioned an anthelmintic parbendazole to treat HNSCC, which revealed a therapeutic utility and provided a new treatment option for human can_x0002_cers.Our study repositioned an anthelmintic parbendazole to treat HNSCC, which revealed a therapeutic utility and provided a new treatment option for human cancers.",35646536
Ketotifen,DB00920,3827,HRH1,Allergic conjunctivitis,,,IgG,SARS-CoV-2 infection,Cytopathic Effect (CPE) Assay; Yield Reduction Assay; Cytotoxicity Assay,,Cytopathic effect CPE assay; Yield reduction assay; Cytotoxicity assay,,,"In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2",33810356
Naproxen,DB00788,156391,PGH2; PGH1,Allergy; Asthma; Osteoarthritis; Pain,,,Vero E6 cells,SARS-CoV-2 infection,Cytopathic Effect (CPE) Assay; Yield Reduction Assay; Cytotoxicity Assay,,Cytopathic effect CPE assay; Yield reduction assay; Cytotoxicity assay,,,"In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2",33810356
Indomethacin,DB00328,3715,PGH2,Allergy; Asthma; Rheumatoid arthritis,,,Vero E6 cells,SARS-CoV-2 infection,Cytopathic Effect (CPE) Assay; Yield Reduction Assay; Cytotoxicity Assay,,Cytopathic effect CPE assay; Yield reduction assay; Cytotoxicity assay,,,"In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2",33810356
Ponatinib,DB08901,24826799,RET; FLT3; KIT; ABL1; BCR,Chronic myeloid leukemia; Acute lymphoblastic leukaemia,,,ECM-receptor interaction pathway,KIT-mutation-bearing melanomas,Establishment of KIT mutant patient-derived tumor xenografts from melanomas; Generation of patient-derived tumor cells; RNA-Sequencing and analysis; Molecular dynamics simulations,Molecular dynamics simulations,Establishment of KIT mutant patient-derived tumor xenografts from melanomas; Generation of patient-derived tumor cells; RNA-Sequencing,,,"Our study of KIT-mutation-and KITWT-bearing melanomas demonstrates that ponatinib is a far more potent inhibitor than is imatinib for KIT-mutation-bearing melanomas and thus underscores that ponatinib should be given priority consideration for the design of precision treatments for melanoma patients triaged to have KIT mutations. Moreover, our work provides a rationale for undertaking clinical trials to examine the repurposing of ponatinib, which is already approved for use in leukemia, for use in treating a large subset of melanoma patients.",31037149
Niclosamide,DB06803,4477,Mitochondrial oxidative phosphorylation in parasites,Cestodes infection,,,Wnt/?2-catenin 47; AKT/mTOR 48; and EGFR mediated signaling pathways,Hepatocellular Carcinoma???HCC??¡ë,Disease gene expression signatures; Drug gene expression profiles; Matching HCC gene expression and drug gene expression to predict drug hits; Culture of HCC cell lines and primary hepatocytes; Establishment of orthotopic HCC; PDX models and drug treatment,,Disease gene expression signatures; Drug gene expression profiles; Matching HCC gene expression and drug gene expression to predict drug hits; Culture of HCC cell lines and primary hepatocytes,Establishment of orthotopic HCC; PDX models; drug treatment,,"Our computational modeling on open data led to the discovery of NEN as a promising clinical candidate for HCC. By combining computational approaches and in vitro and in vivo validations, we provide confidence for the utility and generalizability of our computational approach to identify potential drug candidates in other diseases.",28284560
Suramin,DB04786,5361,FSHR; HPSE,African trypanosomiasis; African sleeping sickness; African river blindness,,,SARS-CoV-2 3CLpro,SARS-CoV-2,Activity Assay of SARS-CoV-2; 3CLpro luorescence experiments; Docking and Molecular Dynamic Simulations of Suramin and Quinacrine with the SARS-CoV-2 3CLpro Structure,Molecular docking; Molecular dynamic simulations,Activity assay of SARS-CoV-2; 3CLpro luorescence experiments,,,"Using docking and molecular dynamics simulations, we identified a possible binding mode and the amino acids involved in these interactions. Our results suggested that suramin, in combination with quinacrine, showed promising synergistic efficacy to inhibit SARS-CoV-2 3CLpro. We suppose that the identification of effective, synergistic drug combinations could lead to the design of better treatments for the COVID-19 disease and repurposable drug candidates offer fast therapeutic breakthroughs, mainly in a pandemic moment.",34068686
Quinacrine,DB01103,237,PA21B,African sleeping sickness; African river blindness,,,SARS-CoV-2 3CLpro,SARS-CoV-2,Activity Assay of SARS-CoV-2; 3CLpro luorescence experiments; Docking and Molecular Dynamic Simulations of Suramin and Quinacrine with the SARS-CoV-2 3CLpro Structure,Molecular docking; Molecular dynamic simulations,Activity assay of SARS-CoV-2; 3CLpro luorescence experiments,,,"Using docking and molecular dynamics simulations, we identified a possible binding mode and the amino acids involved in these interactions. Our results suggested that suramin, in combination with quinacrine, showed promising synergistic efficacy to inhibit SARS-CoV-2 3CLpro. We suppose that the identification of effective, synergistic drug combinations could lead to the design of better treatments for the COVID-20 disease and repurposable drug candidates offer fast therapeutic breakthroughs, mainly in a pandemic moment.",34068686
Fluoxetine,DB00472,3386,SC6A4,Depression,,PI3K-AKT pathway,,Neuroendocrine prostate cancer,high-throughput drug screening and identified fluoxetine originally an FDA-approved antidepressant as candidate therapeutic agent for NEPC. We carried out both in vitro and in vivo experiments to demonstrate the inhibitory effects of fluoxetine on NEPC models and its mechanism in detail.,Virtual screening,RT-qPCR; Western blot; RNA sequencing,Mouse modeling,,Our results demonstrated that fluoxetine effectively curbed the neuroendocrine differentiation and inhibited cell viability by targeting the AKT pathway. Preclinical test in NEPC mice model (PBCre4: Ptenf/f; Trp53f/f; Rb1f/f) showed that fluoxetine effectively prolonged the overall survival and reduced the risk of tumor distant metastases.,36994207
Miconazole,DB01110,4189,CP51,Fungal infection,,,Genes related to ergosterol biosynthesis and encoding drug efflux pumps,Candida infections,Antibiofilm screening assay; Biofilm checkerboard assay; Fungicidal activity assay; Formulation for vaginitis rat model; Vaginal tissue collection and processing,,Antibiofilm screening assay; Biofilm checkerboard assay; Fungicidal activity assay; Vaginal tissue collection and processing,Mouse modeling,,"In vivo, the MCZ-DB combination had significantly improved activity in a vulvovaginal candidiasis rat model compared to that of single-compound treatments. Data from an artificial evolution experiment indicated that the development of resistance against the combination did not occur, highlighting the potential of MCZ-DB combination therapy to treat Candida biofilm-related infections.",32690639
Domiphen,DB11594,3149,fungal CYP450 14?¡À-lanosterol demethylase,Fungal infection,,,/,Candida infections,Antibiofilm screening assay; Biofilm checkerboard assay; Fungicidal activity assay; Formulation for vaginitis rat model; Vaginal tissue collection and processing,,Antibiofilm screening assay; Biofilm checkerboard assay; Fungicidal activity assay; Vaginal tissue collection and processing,Mouse modeling,,"In vivo, the MCZ-DB combination had significantly improved activity in a vulvovaginal candidiasis rat model compared to that of single-compound treatments. Data from an artificial evolution experiment indicated that the development of resistance against the combination did not occur, highlighting the potential of MCZ-DB combination therapy to treat Candida biofilm-related infections.",32690639
Pyrazolanthrone,DB01782,8515,TTK; MK08; MK09; MK10,Oxidative stress; Neuroinflammation; Brain degeneration,,,c-Jun NH2-terminal kinase,Neuroinflammation Induced by MCAO,in silico docking analysis and molecular dynamics simulation to screen potential candidates from the FDA approved drug library using the standard JNK inhibitor SP600125 as a reference. further examined in ischemic stroke using an animal rodent model of focal cerebral ischemia using transient middle cerebral artery occlusion (t-MCAO).,Molecular docking; Molecular dynamics simulations,,Mouse modeling,,"Our results demonstrated that the novel FDA-approved medications attenuate ischemic stroke-induced neuronal degeneration, possibly by inhibiting JNK3. Being FDA-approved safe medications, the use of these drugs can be clinically translated for ischemic stroke-associated brain degeneration and other neurodegenerative diseases associated with oxidative stress and neuroinflammation.",33384558
Gestrinone,DB11619,27812,ESR1,Endometriosis; Breast cancer,,,of JNK/C-Jun,Gynecological cancers,A nationwide population-based retrospective cohort study; RT-qPCR; Western blot; Flow cytometry,,A nationwide population-based retrospective cohort study; RT-qPCR; Western blot; Flow cytometry,,,"Analyses of both the NHIRD and CSMUH databases revealed that gestrinone may reduce the risk of gynecological cancer. Cellular experiments verified the anticancer effects of gestrinone, which effectively and specifically inhibited the growth of HeLa cervical cancer cells, decreased P21 expression via JNK phosphorylation, and induced apoptosis. Combining the results of clinical database analysis and cell experiments, our findings prove that gestrinone has the potential to protect against cancer through regulation of the JNK-P21 axis.",34921996
Azelastine,DB00972,2267,HRH1,Allergic conjunctivitis,,,entry receptor ACE2,SARS-CoV-2,Western blotting; ACE2h/cell membrane chromatography (ACE2h/CMC); Surface plasmon resonance (SPR) analysis; Molecular docking; Pseudovirus infection assay,Molecular docking,Western blot; ACE2h/cell membrane chromatography (ACE2h/CMC); SPR analysis; Pseudovirus infection assay,,,"We found that the antihistamine azelastine can inhibit the entry of pseudoviruses into cells in vitro in combination with ACE2. Azelastine is expected to become a valuable dual-target clinical candidate drug for inhibiting the virus and alleviating the inflammation of COVID-19. At the same time, azelastine can also be modified as a lead compound to develop more effective anti-SARS-CoV-2 drugs. We hope our work can provide reasonable help for the drug repurposing for COVID-19 treatment.",34052578
Verteporfin,DB00460,5362420,CNV,Macular degeneration; Psoriasis vulgaris,,,NUP107,IDH Mutant Gliomas,High-Throughput FDA Compounds Screening on DMA; MTT Assay; CellTiter-Glo Cell Viability Assay; Soft Agar Anchorage-Independent Growth Assay; Western Blot; Mass Spectrometry Analysis; Immunofluorescence and Microscopy,,High-Throughput FDA compounds screening; MTT assay; CellTiter-Glo cell viability assay; Soft agar anchorage-independent growth assay; Western blot; Mass spectrometry; Immunofluorescence and Microscopy,,,"Futhermore, we investigated the biological mechanism behind the killing effect of VP. Our findings suggest that nucleoporins, rather than YAP1, are the targets of VP, and we identified NUP107 as a predicted upstream regulator for VP response. Furthermore, CGGA data suggests that NUP107 may serve as a molecular marker for VP treatment and correlate with patient survival. Our study also highlights the potential of nucleopore complex (NPC) targeting as a novel pathway for the treatment of IDH1mut gliomas.",37162029
Sulfasalazine,DB00795,5359476,TNF-?¡À,Rheumatoid arthritis; Irritable bowel syndrome,,,Ts from T. cruzi (TcTS),Chagas disease,Clustering and ligand-amino acid contact analysis; In vitro trypanocidal assays,,Clustering and ligand-amino acid contact analysis; Trypanocidal assays,,,The anti-inflammatory sulfasalazine showed moderate (37.6%) trans-sialidase inhibition. Sulfasalazine reduced 61% of parasitemia at 6 h during an in vivo assay.,28364659
Manidipine,DB09238,4008,CYSP,Hypertension,,,UL54 promoter,Human cytomegalovirus (HCMV) infections,Plaque reduction assays; Cytotoxicity assays; Quantitative real-time PCR; Western blot; Cell transfections and adenoviral transductions,,Plaque reduction assays; Cytotoxicity assays; RT-qPCR; Western blot; Cell transfections; Adenoviral transductions,,,"We explored the potential to repurpose manidipine dihydrochloride (MND), a calcium antagonist clinically approved to treat hypertension, as a new anti-HCMV agent. MND emerged in a previous drug repurposing screen to find early inhibitors of HCMV replication, and now we confirm that it inhibits in the low micromolar range the replication of different HCMV strains, including clinical isolates and viruses resistant to approved DNA polymerase inhibitors. The antiviral activity of MND is specific for HCMV over different both DNA and RNA viruses.",29274844
Diiodohydroxyquinoline,DB09115,3728,cytochrome b,fungal infection; Parasitic infection,,,p53; NQO1,Cancer,Annexin V-FITC/propidium iodide analysis of apoptosis; Molecular docking study on NQO-1; Molecular dynamics studies,Molecular docking; Molecular dynamics simulations,Annexin V-FITC/propidium iodide analysis of apoptosis,,,"In this work, we provided a framework for the successful repurposing of the old anti-parasitic iodoquinol into effective anti-tumor agents. This was intuitively designed by incorporating previously reported anti-cancer pharmacophores into the main scaffold of iodoquinol/clioquinol and synthetically achieved by subjecting iodoquinol to oxidationfollowed by reaction with appropriate amines.",34091287
Acenocoumarol,DB01418,54676537,VKOR1,Thrombosis,,,NF-?oB,"Chronic inflammatory diseases (e.g., atopic dermatitis and psoriasis)",MTT Assay; Measurement of NO Production; Measurement of PGE2 and Cytokines; Western Blot,,MTT assay; Measurement of NO production; Measurement of PGE2 and cytokines; Western blot,,,"Considering these results, acenocoumarol can be considered as a possible candidate for repurposing as an anti-inflammatory agent. However, further studies are needed to fully understand the role of cellular signaling pathways other than the MAPK and NF-?oB pathways, which may be involved in the anti-inflammatory activity of acenocoumarol.",36903321
Montelukast,DB00471,5281040,CLTR1,Allergic rhinitis; Exercise-induced bronchospasm; Asthma,,,spike/ACE-2),SARS-CoV-2,Molecular modeling studies; Noncovalent docking; MD simulations and MM/GBSA analyses; The 3CL Protease enzyme inhibition assay; The 3CL Protease enzyme inhibition assay; Virus neutralization assay using xCELLigence MP RTCA,Molecular docking; Molecular modeling; MD simulations;,The 3CL Protease enzyme inhibition assay; The 3CL Protease enzyme inhibition assay; Virus neutralization assay,,,"Our results show that montelukast has a dual inhibitor effect and exerts its effect on SARS-CoV-2 by interference with the entry of the virus into the host cell (via spike/ACE-2) as well as inhibiting the 3C-like protease, which is responsible for functional protein maturation. Our computational results also showed the effect of montelukast on the alpha, beta, and delta variants, and its effect on alpha and beta variants was also confirmed by pseudovirus neutralization assays. Thus, in the current study, our integrated in silico and combined in vitro experiments show the effect of montelukast on SARS-CoV-2.",34678509
Quinacrine,DB01103,237,PA21B,Plasmodium infection; Giardia infection,,,V-ATPase,Atheter-related bloodstream infections,Filamentation assays; Vacuolar morphology and fluorescence imaging,,Filamentation assays; Vacuolar morphology; Fluorescence imaging,,,"These experiments indicate that QNC is active against C. albicansgrowth in a pH-dependent manner. Although QNC activity is not biofilm specific, QNC is effective in the prevention and treatment of biofilms. QNC antibiofilm activity likely occurs via several independent mechanisms: vacuolar alkalinization, inhibition of endocytosis, and impaired filamentation",25288082
Rosiglitazone,DB00412,77999,PPAR-?3,Diabete,,,STAT1,Human adenoviruses (HAdVs,RNA Extraction cDNA Library Preparation and Sequencing; Cytopathic effect (CPE) inhibition assays; Viral plaque reduction assay; Quantitative PCR of viral DNA; Western blot,,CPE inhibition assays; Viral plaque reduction assay; RT-qPCR; Western blot,Mouse modeling,,The above reports of rosiglitazone's antiviral activity suggest that rosiglitazone inhibits virus infections via inhibition of inflammatory cell responses or promotion of immune cell differentiation.,32353383
Enviroxime,,5748733,Rhinovirus 3C protease,Virus infection,,,CVB,Type I diabetes,Ten drugs with different antiviral mechanisms were analysed for their efficacy against prototype strains of type B coxsackieviruses in A549 cells. Cell viability was quantified in fixed cells using a colorimetric assay. Median effective dose was interpolated from the triplicated experiments and the dosea€¡°response curves were generated for each druga€¡°virus combination. Drug cytotoxicity was similarly quantified and selectivity indices calculated.,,Colorimetric assay,,,"Hizentra, enviroxime, pleconaril, ribavirin, and favipiravir are effective against type B coxsackieviruses in vitro in their therapeutic serum concentrations. These antiviral drugs are therefore attractive candidates for type 1 diabetes prevention/treatment trials. They can also be used in other clinical conditions caused by type B coxsackieviruses.",31705692
Pleconaril,DB05105,1684,CAPSD,Virus infection,,,CVB,Type I diabetes,Ten drugs with different antiviral mechanisms were analysed for their efficacy against prototype strains of type B coxsackieviruses in A549 cells. Cell viability was quantified in fixed cells using a colorimetric assay. Median effective dose was interpolated from the triplicated experiments and the dosea€¡°response curves were generated for each druga€¡°virus combination. Drug cytotoxicity was similarly quantified and selectivity indices calculated.,,Colorimetric assay,,,"Hizentra, enviroxime, pleconaril, ribavirin, and favipiravir are effective against type B coxsackieviruses in vitro in their therapeutic serum concentrations. These antiviral drugs are therefore attractive candidates for type 1 diabetes prevention/treatment trials. They can also be used in other clinical conditions caused by type B coxsackieviruses.",31705692
Ribavirin,DB00811,37542,IMDH1,Hepatitis C virus infection,,,CVB,Type I diabetes,Ten drugs with different antiviral mechanisms were analysed for their efficacy against prototype strains of type B coxsackieviruses in A549 cells. Cell viability was quantified in fixed cells using a colorimetric assay. Median effective dose was interpolated from the triplicated experiments and the dosea€¡°response curves were generated for each druga€¡°virus combination. Drug cytotoxicity was similarly quantified and selectivity indices calculated.,,Colorimetric assay,,,"Hizentra, enviroxime, pleconaril, ribavirin, and favipiravir are effective against type B coxsackieviruses in vitro in their therapeutic serum concentrations. These antiviral drugs are therefore attractive candidates for type 1 diabetes prevention/treatment trials. They can also be used in other clinical conditions caused by type B coxsackieviruses.",31705692
Favipiravir,DB12466,492405,RPOA; RPOB; RPOC; RPOZ,Influenza virus infection,,,CVB,Type I diabetes,Ten drugs with different antiviral mechanisms were analysed for their efficacy against prototype strains of type B coxsackieviruses in A549 cells. Cell viability was quantified in fixed cells using a colorimetric assay. Median effective dose was interpolated from the triplicated experiments and the dosea€¡°response curves were generated for each druga€¡°virus combination. Drug cytotoxicity was similarly quantified and selectivity indices calculated.,,Colorimetric assay,,,"Hizentra, enviroxime, pleconaril, ribavirin, and favipiravir are effective against type B coxsackieviruses in vitro in their therapeutic serum concentrations. These antiviral drugs are therefore attractive candidates for type 1 diabetes prevention/treatment trials. They can also be used in other clinical conditions caused by type B coxsackieviruses.",31705692
Niclosamide,DB06803,4477,ATP synthase,Cestodes infection,,,STZ,Diabetesa€?induced endothelial dysfunction,Vascular Reactivity Studies; Western Blotting,,Vascular reactivity; Western Blot,,,"In the present study, we demonstrated for the first time that Nic improves diabetes-induced endothelial dysfunction and the possible mechanism of this effect might be partly attributed to the activation of NO/cGMP signaling in rat thoracic aorta.",33772737
Nitazoxanide,DB00507,41684,PNO,Cryptosporidiosis; Giardiasis; Diarrhea,,,TLR7; type I interferons; IL18; IL-1?2,Newcastle disease virus,Cytotoxicity assay; Virus titration and infection; Dose-dependent response of NTZ; Cytokine profiling,,Cytotoxicity assay; Virus titration and infection; Dose-dependent response of NTZ; Cytokine profiling,,,Encouraging results from the present study warrants repurposing NTZ as a drug for the treatment of viral infection in poultry. It will also pave the way towards understanding of similar effect against other animal pathogens.,32403005
Riociguat,DB08931,11304743,GUC2D,Pulmonary arterial hypertension,,,TRPC6,Podocyte Injury,RNA Isolation and Quantitative PCR Analysis; Nitric Oxide Detection; cGMP ELISA; Immunohistochemistry; Western Blot Analyses; ntracellular Ca2+ Measurements by Fura-2 Ratiometry,,RNA sequencing; RT-qPCR; Nitric oxide detection; ELISA; Immunohistochemistry; Western blot; Ntracellular Ca2+ Measurements by Fura-2 Ratiometry,,,"NO and Riociguat stimulated cGMP synthesis in podocytes, decreased Adriamycin-induced TRPC6 expression, inhibited the Adriamycin-induced TRPC6-mediated Ca2+ influx and reduced podocyte injury.",34830371
Propranolol,DB00571,4946,ADRB1,Migraine,,,T cells,Colorectal cancer,Mouse tumor models; Extraction of immune cells; Isolation and culture of spleen T cells; Flow cytometry and fluorescently antibodies; Histological analysis immunohistochemistry and TUNEL staining; RNA-seq profiling and analysis; Single-cell RNA-seq analysis,,Extraction of immune cells; Isolation and culture of spleen T cells; Flow cytometry and fluorescently antibodies; Histological analysis immunohistochemistry and TUNEL staining; RNA sequencing,Mouse modeling,,"We discovered that propranolol (Prop), a non-selective ?21 and ?22 adrenergic receptor blocker, significantly inhibited the development of subcutaneous CT26 CRC and AOM/DSS-induced CRC models.",37054937
Lithium chloride,DB16607,433294,GSK3A,Bipolar disorder; Methhemeglobinemia,,,GSKIII,Neurological deficits associated with OP exposure,Live Imaging and Analysis; Cell Lysates; Immunoblotting and Analysis,,Live imaging and analysis; Cell lysates; Immunoblotting,,,"The results indicated that both LiCl and MB prevented DFP-induced impairments in anterograde and retrograde axonal transport velocities in a concentration dependent manner. While in vivo studies will be required to confirm our in vitro findings, these experiments support the potential of LiCl and MB as repurposed drugs for the treatment of the long-term neurological deficits associated with OP exposure (currently an unmet medical need).",31962143
Methylene blue,DB09241,6099,methemoglobin,Bipolar disorder; Methhemeglobinemia; Acquired methemoglobinemia,,,GSKIII,Neurological deficits associated with OP exposure,Live Imaging and Analysis; Cell Lysates; Immunoblotting and Analysis,,Live imaging and analysis; Cell lysates; Immunoblotting,,,"The results indicated that both LiCl and MB prevented DFP-induced impairments in anterograde and retrograde axonal transport velocities in a concentration dependent manner. While in vivo studies will be required to confirm our in vitro findings, these experiments support the potential of LiCl and MB as repurposed drugs for the treatment of the long-term neurological deficits associated with OP exposure (currently an unmet medical need).",31962143
Siramesine,DB06555,9829526,ADA1A; ADA1B; ADA1D,Depression; Anxiety,,,sigma-1 receptor and Erg2,Fungal infections,Minimum Biofilm Eradication Assay; Modulation of Ergosterol Biosynthesis; Molecular Docking,Molecular docking,Minimum biofilm eradication assay; Modulation of ergosterol biosynthesis,,,"The results showed susceptibility of Candida species to siramesine with MIC at concentration 12.5 ??g/mL, whereas other candidates had no antifungal activity. Siramesine was also effective against in vitro biofilm formation and already formed biofilm was reduced following 24 h treatment with a MBEC range of 50a€¡°62.5 ??g/mL. Siramesine is involved in modulation of ergosterol biosynthesis in vitro, which indicates it is a potential target for its antifungal activity.",34201401
Dihydroergotamine,DB00320,10531,DRD2,Headaches; Migraine,,,TGF?2R2,Liver fibrosis,Food and Drug Administration-approved drugs were screened for binding affinity with TGF?2R2 by virtual molecular docking. We identified 6 candidates and further explored their potential by Cell Counting Kit-8 (CCK-8) cell cytotoxic experiment to validate toxicity and titrated the best cellular working concentrations. Next we further demonstrated the detailed molecular working mechanisms using mutagenesis analysis. Finally we used a mouse model to investigate its potential anti-liver fibrosis effect.,Molecular docking,Cell cytotoxic experiment,Mouse modeling,,"Dihydroergotamine (DHE) shows great ability in reducing fibrotic gene expressions such as collagen, p-SMAD3, and ?¡À-SMA in TGF?2 induced cellular model of liver fibrosis in LX-2 cells.",37346154
Bromhexine,DB09019,2442,Mucin,Sjogren syndrome,,,mNav1.6; mNav1.7; mNav1.9; and hNav1.7-hNav1.9.,Antiallodynic agent,Oxaliplatin (a single intraperitoneal dose of 10 mg/kg) induced tactile allodynia and cold hyperalgesia in CD-1 mice and the effectiveness of single-dose or repeated-dose bromhexine and ambroxol to attenuate pain hypersensitivity was assessed in von Frey and cold plate tests. Additionally Veber analysis and molecular docking experiments of bromhexine on mouse (m) and human (h) Nav1.6-1.9 were carried out.,Molecular docking,Von Frey and cold plate tests; Veber analysis,,,The conversion of bromhexine to other than ambroxol active metabolites should be considered when interpreting some of its in vivo effects. Nav-blocking properties of bromhexine (and previously also predicted for ambroxol) might underlie its ability to attenuate pain caused by oxaliplatin.,32651960
Bazedoxifene,DB06401,154257,ESR1,Osteopetrosis,,,GP130,Persistent HPV (Human Papillomavirus) infection,Cell Proliferation Assay; Wound Healing Migration Assay; Matrigel Invasion Assay; Colony Formation; Western Blot; Annexin V and Propidium Iodide (PI) Staining for Apoptosis Assay; Xenograft in Mouse,,Cell proliferation assay; Wound healing migration assay; Matrigel invasion assay; Colony formation; Western blot; Annexin V and Propidium Iodide (PI) Staining for Apoptosis Assay,Mouse xenograft,,"Our research demonstrates that lncRNA SRA can act as an inhibitor of HPV-positive cervical cancer cell progression. In this study, we investigated the anticancer properties of Bazedoxifene in HPV-positive cervical cancer cells and confirmed that Bazedoxifene inhibits the GP130/STAT3 pathway and suppresses the EMT sub-signal. Our research can provide a basis for cervical cancer replacement therapy.",34445405
Sodium oxamate,,5242,LDH,Type 2 diabetes,,,PI3K/AKT,Cervical cancer,Apoptosis antibody array and Western blot; Flow cytometry: Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,Apoptosis antibody array; Western blot; Flow cytometry; Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,,"Through flow cytometry, Western blot, and protein microarray experiments, we found TT-induced apoptosis on HeLa, CaSki, and SiHa through the caspase 3 intrinsic pathway, including the critical proapoptotic proteins BAD, BAX, cytochrome-C, and p21. In addition, mTOR and S6K phosphorylated proteins were inhibited in the three cell lines. Also, we show an anti-migratory activity of the TT, suggesting other targets of the drug combination in the late CC stages.",37223676
Doxorubicin,DB00997,31703,TOP2A; TOP2B; TERT,Type 2 diabetes; Solid tumour/cancer; Hepatocellular carcinoma; Breast cancer,,,PI3K/AKT,Cervical cancer,Apoptosis antibody array and Western blot; Flow cytometry: Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,Apoptosis antibody array; Western blot; Flow cytometry; Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,,"Through flow cytometry, Western blot, and protein microarray experiments, we found TT-induced apoptosis on HeLa, CaSki, and SiHa through the caspase 3 intrinsic pathway, including the critical proapoptotic proteins BAD, BAX, cytochrome-C, and p21. In addition, mTOR and S6K phosphorylated proteins were inhibited in the three cell lines. Also, we show an anti-migratory activity of the TT, suggesting other targets of the drug combination in the late CC stages.",37223676
Metformin,DB00331,4091,ACACB; S47A1,Type-2 diabetes,,,PI3K/AKT,Cervical cancer,Apoptosis antibody array and Western blot; Flow cytometry: Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,Apoptosis antibody array; Western blot; Flow cytometry; Annexin V-FITC apoptosis detection; Terminal deoxynucleotidyl transferase dUTP nick end labelling assay; Wound healing assay,,,"Through flow cytometry, Western blot, and protein microarray experiments, we found TT-induced apoptosis on HeLa, CaSki, and SiHa through the caspase 3 intrinsic pathway, including the critical proapoptotic proteins BAD, BAX, cytochrome-C, and p21. In addition, mTOR and S6K phosphorylated proteins were inhibited in the three cell lines. Also, we show an anti-migratory activity of the TT, suggesting other targets of the drug combination in the late CC stages.",37223676
Dimethyl Fumarate,DB08908,637568,Nrf2,Multiple Sclerosis,,,NRF2,Parkinson's Disease,Immunoblotting; Analysis of mRNA levels by quantitative real-time polymerase chain reaction; Phagocytosis assay; Immunocytochemistry,,Immunoblotting; Analysis of mRNA levels by quantitative real-time polymerase chain reaction; Phagocytosis assay; Immunocytochemistry,,,"These experiments provide a compelling rationale for targeting NRF2 with DMF as a therapeutic strategy to reinforce endogenous brain defense mechanisms against PD-associated synucleinopathy. Conclusion: DMF is ready for clinical validation in PD. Antioxid. Redox Signal. 25, 61a€¡°77.",27009601
Maraviroc,DB04835,3002977,CCR5,Human immunodeficiency virus infection; Chronic obstructive pulmonary disease,,,IL-6 receptor,Metastatic triple-negative breast cancer,Mouse xenograft studies; Immunofluorescence and immunohistochemical analysis,,Immunofluorescence and immunohistochemical analysis,Mouse xenograft,,"Taken together, these studies confirmed that IL-6 and CCL5 function as critical molecules in TNBC growth and metastasis. Furthermore, maraviroc and tocilizumab could be repurposed and provide a new clinical approach to treat TNBC.",29898755
Niclosamide,DB06803,4477,ATP synthase,Cestodes infection,,,S100A4,HMGA2-Overexpressing Human Colorectal Cancer,Bioinformatics Analysis of Public Data; Microarray; Gene Set Enrichment Analysis (GSEA) and Connectivity Map (CMap); RNA Sequencing and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Analysis; RT-qPCR; Western blot; ELISA,Virtual screening,Microarray; RNA Sequencing; RT-qPCR; Western blot; ELISA,,,"The results of RNA sequencing provide an alternative explanation for the selective anticancer activity by downregulating cell cycle-related genes in HMGA2-overexpressing cells. Nevertheless, our study provides a basis for treating HMGA2-overexpressing colorectal cancer by niclosamide, and the exact mechanism of action warrants further investigation.",31581665
Clenbuterol,DB01407,2783,ADRB2,Asthma; Chronic breathing disorder,,,?22-adrenergic receptor,Down syndrome,Isolation and culture of SVZ neural progenitor cells; Neural progenitor cell proliferation and differentiation,,Isolation and culture of SVZ neural progenitor cells; Neural progenitor cell proliferation and differentiation,,,The current results suggest that treatment with ?22-AR agonists may be a therapy of choice in order to correct dendritic development but is not suitable to rescue neurogenesis. It can be envisaged that combined therapy with CLEN or SALM and a drug than restores neurogenesis may represent a potential strategy for the overall restoration of brain development in DS.,32325119
Salmeterol,DB00938,5152,ADRB2,Asthma; Chronic obstructive pulmonary disease,,,?22-adrenergic receptor,Down syndrome,Isolation and culture of SVZ neural progenitor cells; Neural progenitor cell proliferation and differentiation,,Isolation and culture of SVZ neural progenitor cells; Neural progenitor cell proliferation and differentiation,,,The current results suggest that treatment with ?23-AR agonists may be a therapy of choice in order to correct dendritic development but is not suitable to rescue neurogenesis. It can be envisaged that combined therapy with CLEN or SALM and a drug than restores neurogenesis may represent a potential strategy for the overall restoration of brain development in DS.,32325119
Rifabutin,DB00615,6323490,RNA polymerase,Mycobacterium infection; Tuberculosis,,,/,M. abscessus lung disease,Single-point growth inhibition screening assay; Growth inhibition dose-response and bactericidal assays; Rifabutin preexposure assay,,Single-point growth inhibition screening assay; Growth inhibition dose-response and bactericidal assays; Rifabutin preexposure assay,,,"Surprisingly, the rifampin derivative rifabutin had MICs of 3 ?¡À 2 ??M (3 ??g/ml) against the screening strain, the reference strains M. abscessus subsp. abscessus ATCC 19977, M. abscessussubsp. bolletii CCUG 50184-T, and M. abscessus subsp. massiliense CCUG 48898-T, as well as against a collection of clinical isolates. Furthermore, rifabutin was active against clarithromycin-resistant strains. In conclusion, rifabutin, in contrast to rifampin, is active against the Mycobacterium abscessus complex bacteria in vitro and may be considered for treatment of M. abscessus lung disease.",28396540
Liraglutide,DB06655,16134956,GLP1R,Type-2 diabetes; Obesity,,,?2-cell; exendin-4,Type 1 diabetes,Intraperitoneal Glucose Tolerance Test and Insulin Tolerance Test; Immunofluorescence Staining and Histometric Analysis; In vivo Tracking of Liraglutide; Islets and ?2-Cell Line; Gene Expression Analysis,,Intraperitoneal glucose tolerance test; Insulin tolerance test; Immunofluorescence staining and histometric analysis; Islets and ?2-Cell Line; Gene expression analysis,Tracking of Liraglutide,,"In conclusion, liraglutide, a repurposed compound, ameliorates hyperglycemia in experimental type 1 diabetes. Our results point to ?2-cell replacement, including transdifferentiation and neogenesis, as aiding factor. Liraglutide could be a candidate to restore ?2-cell mass in combined therapies, together with an immunomodulatory strategy to arrest autoimmunity.",32477262
Dipyridamole,DB00975,3108,PDE5A,Hypertension,,,phosphodiesterase,Lymphoid neoplasms,Population study; patient study,Population study,,,Patient study,"To sum up, dipyridamole use was associated with a significantly reduced risk of lymphoid neoplasms, especially B-cell lymphoma. Furthermore, dipyridamole use did not increase the incidence of gastrointestinal bleeding.",34553368
Amitriptyline,DB00321,2160,SC6A4; SC6A2,Congestive heart failure; Hypertension; Depression,,,,Epileptic encephalopathy,High-throughput screening; Quantitative PCR methods,High-throughput screening,RT-qPCR,,,"Four drugs of potential clinical interesta€¡±amitriptyline, carvedilol, nilvadipine, and carbamazepinea€¡±were further investigated and demonstrated concentration-dependent inhibition of sodium channel currents.",29574705
Carvedilol,DB01136,2585,Adrenergic receptors,Congestive heart failure; Hypertension; Depression,,,,Epileptic encephalopathy,High-throughput screening; Quantitative PCR methods,High-throughput screening,RT-qPCR,,,"Four drugs of potential clinical interesta€¡±amitriptyline, carvedilol, nilvadipine, and carbamazepinea€¡±were further investigated and demonstrated concentration-dependent inhibition of sodium channel currents.",29574705
Nilvadipine,DB06712,4494,CAC1C; CAC1D,Congestive heart failure; Hypertension; Depression,,,,Epileptic encephalopathy,High-throughput screening; Quantitative PCR methods,High-throughput screening,RT-qPCR,,,"Four drugs of potential clinical interesta€¡±amitriptyline, carvedilol, nilvadipine, and carbamazepinea€¡±were further investigated and demonstrated concentration-dependent inhibition of sodium channel currents.",29574705
Carbamazepine,DB00564,2554,voltage-gated sodium channels,Congestive heart failure; Hypertension; Depression; Epilepsy; Type-1 diabetes; Gastric adenocarcinoma,,,,Epileptic encephalopathy,High-throughput screening; Quantitative PCR methods,High-throughput screening,RT-qPCR,,,"Four drugs of potential clinical interesta€¡±amitriptyline, carvedilol, nilvadipine, and carbamazepinea€¡±were further investigated and demonstrated concentration-dependent inhibition of sodium channel currents.",29574705
Atorvastatin,DB01076,60823,HMDH,Cardiovascular disease,,,ergosterol,Vulvovaginal and oral candidiasis,In this study we evaluated the antifungal activity of atorvastatin by in vitro tests to determine the minimum inhibitory concentration against azole resistant Candida albicans and its mechanisms of action. Moreover the efficacy of both atorvastatin-loaded oral and vaginal emulgels (0.75% 1.5% and 3% w/w) was evaluated by means of in vivo experimental models of oral and vulvovaginal candidiasis respectively.,,Antifungal susceptibility testing; Sorbitol protection assay; Ergosterol effect assay,Experimental models of oral and vulvovaginal candidiasis,,"The results showed that atorvastatin minimal inhibitory concentration against C. albicans was 31.25 ??g/ml. In oral candidiasis experiments, the group treated with oral emulgel containing 3.0% atorvastatin showcased total reduction in fungal load after nine days of treatment. Intravaginal delivery atorvastatin emulgel showed considerable effectiveness at the concentration of 3% (65% of fungal burden reduction) after nine days of treatment. From these findings, it is possible to assert that atorvastatin may be promising for drug repositioning towards the treatment of these opportunistic mycoses.",32823281
Zidovudine,DB00495,35370,FLT3; POL,Human immunodeficiency virus infection,,,bacterial thymidine kinase,Multidrug-resistant (MDR) Enterobacterales,Checkerboard assay; Timea€¡°kill assay; In vivo toxicity in Galleria mellonella; Galleria mellonella treatment assay,,Checkerboard assay; Timea€¡°kill assay,Toxicity in Galleria mellonella; Galleria mellonella treatment assay,,"Fosfomycin + zidovudine presented greater larval survival (20a€¡°50%) than monotherapy. Synergistic activity was observed for fosfomycin + zidovudine in 69.4% of the tested strains. In vivo experiments confirmed the enhanced effectiveness of the combination. The zidovudine concentrations tested here can be reached in human serum using the actual licensed dosage, therefore this combination deserves further clinical investigation.",34010710
Fosfomycin,DB00828,446987,MURA,Bacterial infection,,,MurA,Multidrug-resistant (MDR) Enterobacterales,Checkerboard assay; Timea€¡°kill assay; In vivo toxicity in Galleria mellonella; Galleria mellonella treatment assay,,Checkerboard assay; Timea€¡°kill assay,Toxicity in Galleria mellonella; Galleria mellonella treatment assay,,"Fosfomycin + zidovudine presented greater larval survival (20a€¡°50%) than monotherapy. Synergistic activity was observed for fosfomycin + zidovudine in 69.4% of the tested strains. In vivo experiments confirmed the enhanced effectiveness of the combination. The zidovudine concentrations tested here can be reached in human serum using the actual licensed dosage, therefore this combination deserves further clinical investigation.",34010710
Deferoxamine,DB00746,2973,Iron ions,Acute iron or aluminum toxicity,,,SRSF7,Pompe disease,RNA sequencing (RNA-seq) and analysis of DEGs; Hybrid EGFP-GAA minigene construction; Western blot,,RNA sequencing (RNA-seq) and analysis of DEGs; Hybrid EGFP-GAA minigene construction; Western blot,,,"In conclusion, our work provides the first reported RNA-based approach for PD drug repurposing. However, the possibility to use Defe in clinical settings might be taken with caution, since the effects of chronic exposure to an iron chelator of patients who do not present iron overload might not be advisable. Nevertheless, our work provides the basis for the development of more potent chemically modified molecules, which either alone or in combination with ERT could improve the clinical outcome in LO-PD patients carrying the c.-32-13T>G variant.",33426149
Disulfiram,DB00822,3117,AL3A2,Alcohol dependence,,,phosphoglycerate dehydrogenase (PHGDH),Cancer,PHGDH Assay; Dilution Experiment; WT and C116S PHGDH Purification; Mass spectrometry experiments Orbitrap Lumos; Cross-linking experiments; Cell models and cytotoxicity assay,,PHGDH assay; Dilution experiment; WT and C116S PHGDH purification; Mass spectrometry; Cross-linking experiments; Cell models and cytotoxicity assay,,,"In conclusion, in this paper, we have shown that DSF, a FDA-approved aldehyde dehydrogenase inhibitor used as a treatment for chronic alcoholism, and some structural analogues are PHGDH inhibitors. Through biochemical and mass spectrometric experiments, we detailed the mechanism-of-inhibition of PHGDH by DSF and demonstrated that it involves the disruption of the active PHGDH tetramer into either an inactive dimer covalently linked by a disulfide bridge involving Cys116 on adjacent monomers or, to a lesser extent, an inactive monomer intermediate.",30894617
Acarbose,DB00284,9811704,alpha-glucosidase enzymes,Diabetic complication; Type-2 diabetes; Cardiovascular disease,,,Th1-type,Visceral leishmaniasis,Cytotoxicity assay; Inhibition of infection by pre-treatment of L. infantum parasites; Evaluation of mitochondrial membrane potential; Production of reactive oxygen species (ROS); Evaluation of lipid accumulation in the parasites,,Cytotoxicity assay; Inhibition of infection by pre-treatment of L. infantum parasites; Evaluation of mitochondrial membrane potential; Production of reactive oxygen species (ROS); Evaluation of lipid accumulation in the parasites,,,"Concordantly, treatment with ACA significantly increased the levels of neutral lipids, suggesting the occurrence of cell disorders followed by parasite death. Despite the fact that preliminary results imply ACA targets the Leishmania mitochondria, additional studies are certainly necessary to confirm its mechanism of action.",33870453
Norclozapine,DB05766,135409468,ACM1,Schizophrenia,,,tumor necrosis factor alpha (TNF-?¡À??¡ë,Dengue Virus,Inhibitor treatments.; RNA transfection.; Quantitative real-time PCR (qRT-PCR).; Immunofluorescence.,,Inhibitor treatments; RNA transfection; RT-qPCR; Immunofluorescence,,,"We identified three compounds, N-desmethylclozapine, fluoxetine hydrochloride, and salmeterol xinafoate, as dengue virus replication inhibitors in a DENV screening assay. All three inhibitors reduced dengue virus infection with IC50s in the high-nanomolar/low-micromolar range. Cells treated with these inhibitors had low levels of dsRNA and negative-strand intermediates. This finding, along with the time-of-addition and RNA transfection experiments, demonstrated that the inhibitors interfered with early stages of dengue virus RNA replication.",27572397
Fluoxetine,DB00472,3386,SC6A4,Coronavirus Disease 2019 (COVID-19),,,tumor necrosis factor alpha (TNF-?¡À??¡ë,Dengue Virus,Inhibitor treatments.; RNA transfection.; Quantitative real-time PCR (qRT-PCR).; Immunofluorescence.,,Inhibitor treatments; RNA transfection; RT-qPCR; Immunofluorescence,,,"We identified three compounds, N-desmethylclozapine, fluoxetine hydrochloride, and salmeterol xinafoate, as dengue virus replication inhibitors in a DENV screening assay. All three inhibitors reduced dengue virus infection with IC50s in the high-nanomolar/low-micromolar range. Cells treated with these inhibitors had low levels of dsRNA and negative-strand intermediates. This finding, along with the time-of-addition and RNA transfection experiments, demonstrated that the inhibitors interfered with early stages of dengue virus RNA replication.",27572397
Salmeterol,DB00938,5152,ADRB2,Chronic obstructive pulmonary disease,,,tumor necrosis factor alpha (TNF-?¡À??¡ë,Dengue Virus,Inhibitor treatments.; RNA transfection.; Quantitative real-time PCR (qRT-PCR).; Immunofluorescence.,,Inhibitor treatments; RNA transfection; RT-qPCR; Immunofluorescence,,,"We identified three compounds, N-desmethylclozapine, fluoxetine hydrochloride, and salmeterol xinafoate, as dengue virus replication inhibitors in a DENV screening assay. All three inhibitors reduced dengue virus infection with IC50s in the high-nanomolar/low-micromolar range. Cells treated with these inhibitors had low levels of dsRNA and negative-strand intermediates. This finding, along with the time-of-addition and RNA transfection experiments, demonstrated that the inhibitors interfered with early stages of dengue virus RNA replication.",27572397
Tranilast,DB07615,5282230,HRH1; STS,Bronchial asthma; allergic rhinitis; Ocular allergy,,,Sepiapterin Reductase,Neuropathic Pain,Molecular Docking; MD Simulations; Cell-Free Direct hSPR Enzyme Activity Assay; Cellular hSPR Activity Assays; Cell Metabolism and Viability Assays; Flow Cytometry of ROS; Western Blot of BH4 Pathway Enzymes & qPCR of Upstream Gene Expressions; BH4 Quantification by QQQ-MS,Molecular docking; MD simulations,Cell-free direct hSPR enzyme activity assay; Cellular hSPR activity assays; Cell metabolism; Viability assays; Flow cytometry of ROS; Western blot,,,Tranilast was able to inhibit hSPR activity both intracellularly and extracellularly in live cells. Triple quad mass spectrophotometry of cell lysates showed a proportional decrease of BH4 in cells treated with tranilast. Our results suggest that tranilast can act as a potent hSPR inhibitor and therefore is a valid candidate for drug repurposing in the treatment of chronic pain.,31460307
Naproxen,DB00788,156391,PGH2; PGH1,Osteoarthritis; Pain,,,Nucleoprotein,Influenza A virus.,Molecular modeling; Protein expression and purification of wt NP and the Y148A R355A and R361A mutants; Fluorescence; SPR experiments; Cell viability assay by MTT assay; Localization of NP in A549 and MDCK cells infected by influenza A virus in the absence or presence of naproxen as detected by immunofluorescence.,Molecular simulations,Protein expression and purification of wt NP and the Y148A R355A and R361A mutants; Fluorescence; SPR experiments; Cell viability assay by MTT assay; Localization of NP in A549 and MDCK cells infected by influenza A virus in the absence or presence of naproxen as detected by immunofluorescence,,,"Naproxen protected Madin-Darby canine kidney (MDCK) cells against viral challenges with the H1N1 and H3N2 viral strains and was much more effective than other cyclooxygenase inhibitors in decreasing viral titers of MDCK cells. In a mouse model of intranasal infection, naproxen treatment decreased the viral titers in mice lungs. In conclusion, naproxen is a promising lead compound for novel antivirals against influenza A virus that targets the nucleoprotein in its RNA binding groove.",23459490
Cardenolide,,53957771,sodium-potassium pump,Cardenolide of Digitalis lanata,,,Th1-type,Visceral leishmaniasis,We report herein the antileishmanial activity of ?2-acetyl-digitoxin (b-AD) a cardenolide isolated from Digitalis lanata leaves assayed in vitro and in vivo against Leishmania infantum. Results showed direct action of b-AD against parasites as well as efficacy for the treatment of Leishmania-infected macrophages. In vivoexperiments using b-AD-containing Pluronic F127 polymeric micelles (b-AD/Mic) to treat L. infantum-infected mice showed that this composition reduced the parasite load in distinct organs in more significant levels. It also induced the development of anti-parasite Th1-type immunity attested by high levels of IFN-?3 IL-12 TNF-?¡À GM-CSF nitrite and specific IgG2a antibodies in addition to low IL-4 and IL-10 contents along with higher IFN-?3-producing CD4+ and CD8+ T-cell frequency.,,Cytotoxicity assay; Reactive oxygen species (ROS) production; Antibody production,Mouse modeling,,"Comparing the therapeutic effect between the treatments, b-AD/Mic was the most effective in protecting animals against infection, when compared to the other groups including miltefosine used as a drug control. Data found 15 days after treatment were similar to those obtained one day post-therapy. In conclusion, the results obtained suggest that b-AD/Mic is a promising antileishmanial agent and deserves further studies to investigate its potential to treat visceral leishmaniasis.",33851916
Atovaquone,DB01117,74989,PYRD,Pneumocystis pneumonia; Fungal infection,,,?¡À6; integrin ?24; FAK; Src; and Vimentin.,Triple-negative breast cancer (TNBC),In order to study the efficacy of atovaquone in suppressing metastasized breast tumor cells in brain and lungs we performed three in vivo experiments. We demonstrated that oral administration of 50 mg/kg of atovaquone suppressed MDA-MB-231 breast tumor growth by 90% in lungs in an intravenous metastatic tumor model. Anti-metastatic effect of atovaquone was further determined by intracardiac injection of 4T1-luc breast tumor cells into the left ventricle of mouse heart.,,,Mouse modeling,,"Our results showed that atovaquone treatment suppressed the growth of metastatic tumors in lungs, liver and brain by 70%, 50% and 30% respectively. In an intracranial model, the growth of HCC1806-luc brain tumors in atovaquone treated mice was about 55% less than that of control. Taken together, our results indicate the anti-metastatic effects of atovaquone in vitro and in vivo in various breast tumor metastasis models.",34071408
Pyrimethamine,DB00205,4993,FOLR1,Malaria,,,AIMP2-DX2,Lung cancer,pyrimethamine inhibited the level of DX2 (IC50 = 0.73 ??M) in A549 cells expressing nanoluciferase-tagged DX2. In a panel of 5 lung cancer cell lines with various DX2 levels pyrimethamine most potently suppressed the growth of H460 cells which express high levels of DX2 (GI50 = 0.01 ??M). An immunoblot assay in H460 cells showed that pyrimethamine decreased the DX2 level dose-dependently but did not affect the AIMP2 level. Further experiments confirmed that pyrimethamine resulted in ubiquitination-mediated DX2 degradation. In an in vivo mouse xenograft assay using H460 cells intraperitoneal administration of pyrimethamine significantly reduced the tumor size and weight comparable with the effects of taxol without affecting body weight.,,Cell experiment,Mouse xenograft,,"Analysis of tumor tissue showed a considerably high concentration of pyrimethamine with a decreased levels of DX2. These results suggest that pyrimethamine, currently used as anti-parasite drug, could be repurposed to treat lung cancer patients expressing high level of DX2.",32549310
Selamectin,DB11459,9578507,Glutamate-gated chloride channels in parasites,"Parasitic diseases such as river blindness, elephantiasis and scabies",,,,Uveal melanoma,Cell counting kit 8 (CCK8) assay; Western blot analysis; RNA isolation and quantitative real-time PCR (qPCR); Connecting map (cMAP) database screening,Virtual screening,Cell counting kit 8 (CCK8) assay; Western blot; RT-qPCR,,,"In summary, our study shows that selamectin enhanced the sensitivity of UM to cisplatin, through the mechanism of inhibiting cisplatin resistance-associated gene expression and autophagy. These findings may provide a new strategy for the treatment of UM.",37087801
Suramin,DB04786,5361,FSHR; HPSE,African trypanosomiasis,,,E2 envelope protein,Chikungunya virus (CHIKV),Virus Attachment Assay; Bulk Fusion Assay; Immunoblotting and RT-PC; Ubiquitination Assay; In Vivo Mouse Xenograft,,Virus attachment assay; Bulk fusion assay; Immunoblotting and RT-PC; Ubiquitination assay,Mouse xenograft,,"Using molecular modelling studies, we predicted the potential suramin binding sites on the mature spikes of the chikungunya virion. We conclude that suramin interferes with CHIKV entry by interacting with the E2 envelope protein, which inhibits attachment and also interferes with conformational changes required for fusion",32191995
Paroxetine,DB00715,43815,SC6A4,Depression; Anxiety,,,receptor tyrosine kinases a€¡° MET and ERBB3,Human colon cancer,Phospho-RTK array ; Western blot analysis; Annexin V apoptosis analyses,,Phospho-RTK array ; Western blot; Annexin V apoptosis analyses,,,"We speculated that the mode of action of paroxetine might be through the inhibition of two major receptor tyrosine kinases a€¡° MET and ERBB3 a€¡° leading to the suppression of AKT, ERK and p38 activation and induction of JNK and caspase-3 pathways. Moreover, in vivo experiments revealed that treatment of athymic nude mice bearing HT-29 cells with paroxetine remarkably suppressed tumour growth. In conclusion, paroxetine is a potential therapeutic option for patients with colorectal cancer.",30421568
Chloroquine,DB00608,2719,ACKR1,Coronavirus Disease 2019 (COVID-19); Adenovirus; Malaria,,,acid vesicles,Crimean-Congo hemorrhagic fever virus,Plaque reduction assay; Analysis of the anti-CCHFV effect of molecule combinations,,Plaque reduction assay; Analysis of the anti-CCHFV effect of molecule combinations,,,"In this study, chloroquine and chlorpromazine were found to inhibit CCHFV replication in vitro, even if added up to 6 h post infection. Moreover when these two molecules were in combination to ribavirin, a synergistic effect was observed in Vero E6 cells.",25796972
Chlorpromazine,DB00477,2726,DRD2,Malaria; Adenovirus; Schizophrenia,,,Huh7 cell line,Crimean-Congo hemorrhagic fever virus,Plaque reduction assay; Analysis of the anti-CCHFV effect of molecule combinations,,Plaque reduction assay; Analysis of the anti-CCHFV effect of molecule combinations,,,"In this study, chloroquine and chlorpromazine were found to inhibit CCHFV replication in vitro, even if added up to 6 h post infection. Moreover when these two molecules were in combination to ribavirin, a synergistic effect was observed in Vero E6 cells.",25796972
Zafirlukast,DB00549,5717,CLTR1,Asthma,,,Lsr2,Tuberculosis,Screening of NCC; Kirby-Bauer disc diffusion assays; Test of the bactericidal activity of zafirlukast; Semiquantitative RT-PCR.; Intensity-fading MALDI-TOF mass spectrometry assay,,Screening of NCC; Kirby-Bauer disc diffusion assays; Test of the bactericidal activity of zafirlukast; Semiquantitative RT-PCR.; Intensity-fading MALDI-TOF mass spectrometry assay,,,"the presented data suggest inhibition of Lsr2 activity by zafirlukast and a concomitant physiological response by mycobacteria to this inhibition. Not only is zafirlukast now identified as a specific inhibitor of Lsr2 function, but also the application of this drug is clearly bactericidal to M. smegmatis.",23439641
Talazoparib,DB11760,44819241,PARP,Breast cancer; Psoriatic arthritis,,,ACE2 receptor,SARS-CoV-2,Plaque assays.; RT-qPCR.; Time-of-addition experiments.,,Plaque assays.; RT-qPCR.; Time-of-addition experiments.,,,"A promising drug to emerge from COVID therapeutic trials is the nucleoside analog remdesivir, which shows activity against phylogenetically diverse viruses, including Ebola virus, Nipah virus, respiratory syncytial virus (RSV), and coronaviruses such as SARS- and MERS-CoV (51), SARS-CoV-2 (31) and, as reported here, the seasonal human HCoV-NL63.",33468703
WZ3146,,44607360,EGFR,Lung cancer,,,spleen tyrosine kinase (Syk) ; inker for activation of T cell (LAT),Allergic diseases,Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR); western blot; Immunoprecipitation and in vitro tyrosine kinase assay; Passive cutaneous anaphylaxis (PCA),,RT-PCR; Western blot; Immunoprecipitation; Tyrosine kinase assay,,,"Taken together, in this study we show that the pyrimidine derivative, WZ3146, inhibits the IgE-mediated allergic response by inhibiting Lyn and Fyn Src-family kinases, which are initially activated by antigen stimulation in MCs. Therefore, we propose that WZ3146 could be used as a new therapeutic agent for the treatment of allergic diseases.",31526816
Montelukast,DB00471,5281040,CLTR1,Allergic disease; Asthma,,,oncogenic genes,Pancreatic cancer,Histopathological Examination; Immunohistochemistry; Cell Cycle Analysis; Immunoblotting; Tissue Samples Clinical Information and CYSLTR1 Expression in PDAC,,Histopathological examination; Immunohistochemistry; Cell cycle analysis; Immunoblotting; Tissue samples clinical information; CYSLTR1 expression in PDAC,,,Our findings suggest that montelukast suppressed pancreatic carcinogenesis by inhibiting the cellular proliferation of pancreatic cancer cells. Widely used anti-allergic drugs may be used as a chemopreventive treatment for pancreatic cancer.,34299067
Mefloquine,DB00358,4046,Plasmodium falciparum,Malaria,,,mitochondrial DNA,Pathogenic yeasts and molds,Yeast strains and general microbiological methods.; In vitro antifungal susceptibility.; In vitro antifungal susceptibility.; In vitro toxicity assays.,,Yeast strains and general microbiological methods.; Antifungal susceptibility; Antifungal susceptibility; Toxicity assays,,,"The mefloquine derivatives have activity against clinical isolates that are resistant to one or more of the three classes of antifungal drugs currently used to treat invasive fungal infections, indicating that they have a novel mechanism of action.",31907188
Quinacrine,DB01103,237,PA21B,Malaria,,,pol-1,Acute myeloid leukemia,Fluorometric microculture cytotoxicity assay a€¡° FMCA; In vivo study of quinacrine alone and in combination with cytarabine,,Fluorometric microculture cytotoxicity assay a€¡° FMCA,Mouse modeling,,"Taken together, the repositioning potential of quinacrine for treatment of AML is reinforced by demonstrating significant in vivo activity and promising synergies when quinacrine is combined with different agents, including cytarabine, the hypomethylating agent azacitidine and HSP-90 inhibitor geldanamycin.",29100024
Secnidazole,DB12834,71815,Anaerobic microorganisms,Pseudomonas aeruginosa; Bacterial vaginosis; Amoebiasis,,Pseudomonas aeruginosa virulence factors,,Pseudomonas aeruginosa Infection,Quantitative RT-PCR of QS genes; Total RNA extraction for qRT-PCR; Total proteases assay; Elastase assay; Hemolysins assay; Rhamnolipids assay; Pyocyanin assay; Pyoverdin assay,,RT-qPCR; Total proteases assay; Elastase assay; Hemolysins assay; Rhamnolipids assay; Pyocyanin assay; Pyoverdin assay,,,"Production of elastase, hemolysins and total proteases was sig- nificantly decreased in secnidazole-treated bacteria compared to un- treated bacteria as shown in (Fig. 3a, b and c)",30500409
Triclosan,DB08604,5564,Q965D5,Malaria,,C75; orlistat,FASN,Prostate cancer,DNA content analysis; Cell culture; Live imaging and Alamar Blue assay; Fluorescence microscopy; Flow cytometry; Western blot; Quantitative real-time PCR,,DNA content analysis; Cell culture; Live imaging and Alamar Blue assay; Fluorescence microscopy; Flow cytometry; Western blot; RT-qPCR,,,Triclosan is cytotoxic in prostate cancer cells; Triclosan causes a G0/G1 cell cycle arrest and induces apoptosis in PCa cells,25313139
Meclozine,DB00737,4034,NR1I3,Motion sickness,,,FGFR3,Achondroplasia,Alcian blue staining; Total RNA extraction and real-time RT-PCR analysis; Growth assay; Bone explant culture; Western blotting,,Alcian blue staining; RT-PCR; Growth assay; Bone explant culture; Western blot,,,Meclozine facilitates chondrocyte proliferation and mitigates loss of extracellular matrix in FGF2-treated RCS cells; Meclozine mitigates abnormally suppressed differentiation of ATDC5 chondrogenic cells expressing FGFR3-G380R and -K650E in micromass culture; Meclozine attenuates ERK phosphorylation in FGF2- treated RCS cells,24324705
Empagliflozin,DB06292,11949646,SC5A2,Type-1 diabetes,,,human equilibrative nucleoside transporter 1,Blood-brain barrier crossing ability,chromatographic bioassay,,Chromatographic bioassay,,,"First, ligand-based target fishing reveals possible targets for gliflozins. They showed an ability to bind with human equilibrative nucleoside transporter 1, a regulator of adenosine extracellularly",36637096
Canagliflozin,DB09017,24812758,SC5A2,Type-1 diabetes; Type-2 diabetes; Diabetic nephropathy,,,human equilibrative nucleoside transporter 1,Blood-brain barrier crossing ability,chromatographic bioassay,,Chromatographic bioassay,,,"First, ligand-based target fishing reveals possible targets for gliflozins. They showed an ability to bind with human equilibrative nucleoside transporter 1, a regulator of adenosine extracellularly",36637096
Dapagliflozin,DB06292,9887712,SC5A2,Type-2 diabetes,,,human equilibrative nucleoside transporter 1,Blood-brain barrier crossing ability,chromatographic bioassay,,Chromatographic bioassay,,,"First, ligand-based target fishing reveals possible targets for gliflozins. They showed an ability to bind with human equilibrative nucleoside transporter 1, a regulator of adenosine extracellularly",36637096
Suramin,DB04786,5361,FSHR; HPSE,African trypanosomiasis,,,Ser135 residue; NS2B/NS3 proteinase,Zika virus infection,fluorescence spectroscopy; STD NMR spectroscopy; Inhibition assay,,Fluorescence spectroscopy; STD NMR spectroscopy; Inhibition assay,,,The computational analysis showed that suramin block the Ser135 residue and interact with the catalytically histidine residue.,30393012
Levosimendan,DB00922,3033825,TNNC1,Congestive heart failure; Heart failure; Cardiac output syndrome; Pulmonary hypertension,,,serine/threonine-protein kinase RIOK1,Lymphoma,Kinase binding assay; Cancer cell line assay,,Kinase binding assay; Cancer cell line assay,,,Levosimendan can inhibit the proliferation of multiple types of cancer cells,31206508
Honokiol,,72303,PGH2; PGH1; LOX5,Non-alcoholic steatohepatitis (NASH),,,AMPK?31,Non-alcoholic fatty liver (NAFLD),Transcriptomic examination; biotin-streptavidin binding assays; western blot,,Transcriptomic examination; Biotin-streptavidin binding assays; Western blot,,,"Using a primary mouse hepatocyte model, we further confirmed the lipid-lowering and anti-inflammatory effects of honokiol with well-tolerable safety; Honokiol ameliorates high-fat diet (HFD)-induced NAFLD",36932412
Simvastatin,DB00641,54454,HMDH,Hypercholesterolaemia,,,IL-6; TNF-?¡À; IL-1?2,Antibacterial,Gram-negative bacteria outer membrane permeabilization assay; Antibacterial assay; Macromolecular synthesis assay; Proteomics assay; Mitochondrial biogenesis assay; ELISA; ; Cell-free bacterial transcription/translation assay; Synergistic assay; In vitro antibacterial assays,,Gram-negative bacteria outer membrane permeabilization assay; Antibacterial assay; Macromolecular synthesis assay; Proteomics assay; Mitochondrial biogenesis assay; ELISA; ; Cell-free bacterial transcription/translation assay; Synergistic assay; Antibacterial assays,,,Simvastatin causes extensive protein degradation and disrupts cellular homeostasis,37337909
Cefdinir,DB00535,6915944,Bacterial cell wall,Bacterial infection,,,Mtb ?2-lactamase,Tuberculosis (TB),Minimum inhibitory concentration (MIC) Tests; dose-response study,,MIC Tests; Dose response study,,,"In the HFS-TB model, cefdinir showed efficacy against both drug susceptible and MDR-TB without combination of ?2-lactamase inhibitor.",34163361
Nitazoxanide,DB00507,41684,PNO,Diarrhea; Coronavirus Disease 2019 (COVID-19),,,NLRP3,Atherosclerosis,Boyden chamber assay; immunofluorescence staining; western blot,,Boyden chamber assay; Immunofluorescence staining; Western blot,,,The in vitro experiments showed that nitazoxanide and tizoxanide had a mitochondrial uncoupling effect and activated cellular AMPK; The in vivo experiments demonstrated that oral administration of nitazoxanide reduced the increase in serum IL-1?2 and IL-6 levels and suppressed atherosclerosis in Western diet-fed ApoE (-/-) mice,36082580
Protriptyline,DB00344,4976,SC6A2,Depression,,,Acetylcholinesterase (AChE); ?2-secretase (BACE-1); amyloid ?2 (A?2),Alzheimer's disease,biophysical assays; isothermal calorimetry; fluorescence quenching,Virtual screening,Biophysical assays; Isothermal calorimetry; Fluorescence quenching,,,Protriptyline Inhibits AChE Activity by Inducing Conformational Change in the Active Site; Protriptyline Inhibits Ab Self-Assembly; Protriptyline Inhibits Glycation Associated Aggregation of Ab,25141174
Cisplatin,DB00515,2767,TERT,Solid tumour/cancer; Osteosarcoma,,,type III secretion system (T3SS),Nosocomial pathogen Pseudomonas aeruginosa,MIC assay; RNA sequencing; qRT-PCR analysis; P. aeruginosa biofilm killing assay; RAW264.7 macrophage cytotoxicity assay,,MIC assay; RNA sequencing; RT-qPCR; P. aeruginosa biofilm killing assay; RAW264.7 macrophage cytotoxicity assay,,,"In addition, cisplatin treatment induced the expression of a series of genes involved in energy metabolism, which corroborated with previous proteomics work showing that cisplatin could interfere with stress response and energy metabolism in E. coli; Cisplatin showed efficient killing capacity on P. aeruginosa cells from infected mouse corneas and there was a significant reduction in the bacterial loads from the cisplatin treated corneas as compared to the control corneas",30591828
Dimercaprol,DB06782,3080,Heavy metal ions,Poison intoxication,,,SVMPs,Snakebite,clinical trails; screening,Virtual screening,,,Phase-1 clinical trial,Unithiol and other small molecule venom inhibitors therefore have the potential to inhibit a globally diverse range of snake venoms,35372700
Dasatinib,DB01254,3062316,SRC; LCK; FYN; BCR; ABL1,Chronic myelogenous leukaemia; Multiple myeloma,May exacerbate progression of the tumors,,SFKs; BTKs,Type III EBV+ B cell malignancies,Cell culture; flow cytometry; Western blotting; qPCR; immunohistochemistry,,Cell culture; Flow cytometry; Western blot; RT-qPCR; Immunohistochemistry,,,"We found that dasatinib, which is a multi-target kinase inhibitor and already in clinical use for CML and Ph+ ALL, induces cell death in the LCLs in vitro; Dasatinib treatment exacerbates splenomegaly of mice inoculated with EBV-LCLs",32152351
Sulforaphane,DB12422,9577379,Nrf2,Solid tumour/cancer,,,B cell lymphoma 2 (Bcl 2); Bcl 2 associated X protein; cytochrome c; Caspase 3; phosphorylated AKT; phosphorylated nuclear factor ?oB; P53; P27; Cyclin D1; EGFR2; cMyc,Ovarian cancer,Cell culture; migration assay; cell viability assay; immunofluorescence assay; cell proliferation assay; cell wound healing assay; Immunohistochemical (IHC) assay; Western blot; Xenograft,,Cell culture; Migration assay; Cell viability assay; Immunofluorescence assay; Cell proliferation assay; Cell wound healing assay; Immunohistochemical assay; Western blot,Xenograft,,Sulforaphane effectively suppresses human ovarian cancer cell proliferation,30226534
Curcumin,DB11672,969516,CAH2; CAH4; CAH1; CAH12; CAH14; CAH9; CAH6; PGH2; MMP9; MMP13; PGH1; A4; XDH; NOS2; CP3A4; DNM3B,Solid tumour/cancer,,ALDH1A1,NF-?oB; Akt/mTOR; HIF1?¡À,Ovarian cancer,Western blot; In vitro cytotoxicity (MTT) assay; Adhesion assay; Mesothelial clearance assay,,Western blot; MTT assay; Adhesion assay; Mesothelial clearance assay,,,Our experiments provided evidence that curcumin could abolish the sphere-forming capacity of EOC cells in a dose-dependent manner.,27863439
Artesunate,DB09274,6917864,cell membrane,Malaria,,,NFa€?DoB; p38 mitogena€?activated protein kinase (MAPK) signaling,Depression,Behavioral tests,,Behavioral tests,,,"These results indicate that pretreatment with artesunate exerts protective effects against H2O2a€?induced cellular injury.; Together, these results suggest that artesunate exerted antidepressanta€? and anxiolytica€?like effects in mice.",36573693
Suramin,DB04786,5361,FSHR; HPSE,African sleeping sickness; African river blindness; African trypanosomiasis,,VEGF; bFGF,,Breast cancer lung metastasis,Wound healing assay; Cell invasion assay; Endothelial tube formation assay; Cell viability assay; Immunohistochemistry; histological analysis,,Wound healing assay; Cell invasion assay; Endothelial tube formation assay; Cell viability assay; Immunohistochemistry; Histological analysis,,,The In vivo experiment proved that GCS-SM/DOX NP could greatly inhibit breast cancer lung metastases and improve the survival time for mice while not inducing the cardiotoxicity and renal toxicity associated with its free drug counterpart,30528604
Mebendazole,DB00643,4030,Tubulin,Worm infection,,,ABL1; MAPK1/ERK2; MAPK14/p38?¡À,Brain tumors,Cell culture; cell viability assay; gene expression analysis; ; kinase assay; NanoBERT target engagement assay; Thermal-shrift assay; Isothernal-tirration calorimetry; Nano Differential Scanning fluorimetry (nanoDSF),,Cell culture; Cell viability assay; Gene expression analysis; Kinase assay; NanoBERT target engagement assay; Thermal-shrift assay; Isothernal-tirration calorimetry; nanoDSF,,,"Finally, gene silencing demonstrated that MAPK14 is involved in glioblastoma tumor spheroid growth and response to mebendazole treatment; Mebendazole exerts potent anti-proliferative effects against GBM cell lines in vitro",33021050
Ciclopirox,DB01188,2749,cell membrane,Fungal infection,,PERK-dependent endoplasmic reticulum (ER),,Non-small cell lung cancer (NSCLC),Cell culture; Cell viability and proliferation assay; Colony formation assay; In vitro cell migration and invasion assays; qPCR; apoptosis assay; Immunohistochemistry (IHC) staining; Western blot,,Cell culture; Cell viability assay; Gene expression analysis; Kinase assay; NanoBERT target engagement assay; Thermal-shrift assay; Isothernal-tirration calorimetry; nanoDSF,,,"These findings suggested that the anticancer activity of CPX for NSCLC was at least partially via arresting the cell cycle.; These findings indicated that CPX inhibits NSCLC cell migration and invasion through regulating EMT.; Collectively, these results suggest that mitochondrial respiration interruption and increase of ROS might contribute to CPX-induced growth inhibition of the NSCLC cells.",35331268
Riluzole,DB00740,5070,SCNBA,Amyotrophic lateral sclerosis,,,Glutamate,"Niemann-Pick disease, type C1",cell culture; qPCR; Immunofluorescence; Flow Cytometry analysis,,Cell culture; RT-qPCR; Immunofluorescence; Flow cytometry analysis,,,"Decreased expression of EAAT1 protein and functional impairment of glutamate uptake by Npc1 / astrocytes, is consistent with the hypothesis that glutamate-mediated neurotoxicity contributes to NPC1 neuropathology; These data suggest that drugs which decrease endolysosomal glycosphingolipid (miglustat) or unesterified cholesterol (HP?2CD) improve glutamate uptake by Npc1 mutant astrocytes.; The observation that riluzole appears to have more of an impact on astrogliosis also suggests that combining riluzole with an anti-inflammatory drug which suppresses microgliosis may be of benefit.",34802899
Valproic acid,DB00313,3121,GSK3A,Epilepsy; Hypercholesterolemia; Coronavirus Disease 2019 (COVID-19),,,Histone deacetylase inhibitors (HDACi); HMG-CoA reductase (HMGCR),Prostate cancer,Cell proliferation assay; Caspase 3/7 bioluminescence assay; Flow cytometry analysis; Clonogenic agarassay; Western blot; Spheroid-forming assay; Real-time PCR; ; Immunofluorescence assay; Limiting-dilution assay,,Cell proliferation assay; Caspase 3/7 bioluminescence assay; Flow cytometry analysis; Clonogenic agarassay; Western blot; Spheroid-forming assay; Real-time PCR; ; Immunofluorescence assay; Limiting-dilution assay,,,The ability of valproic acid/simvastatin combination to sensitize mCRPC cells to docetaxel and to revert docetaxel-resistance is modulated by mevalonate pathway/YAP axis; Valproic acid and simvastatin combination induces synergistic antitumor effect in prostate cancer cells via concurrent inhibition of the mevalonate pathway,33032653
Simvastatin,DB00641,54454,HMDH,Epilepsy; Hypercholesterolaemia,,,Histone deacetylase inhibitors (HDACi); HMG-CoA reductase (HMGCR),Prostate cancer,Cell proliferation assay; Caspase 3/7 bioluminescence assay; Flow cytometry analysis; Clonogenic agarassay; western blotting; Spheroid-forming assay; Real-time PCR; ; Immunofluorescence assay; Limiting-dilution assay,,Cell proliferation assay; Caspase 3/7 bioluminescence assay; Flow cytometry analysis; Clonogenic agarassay; Western blot; Spheroid-forming assay; Real-time PCR; ; Immunofluorescence assay; Limiting-dilution assay,,,The ability of valproic acid/simvastatin combination to sensitize mCRPC cells to docetaxel and to revert docetaxel-resistance is modulated by mevalonate pathway/YAP axis; Valproic acid and simvastatin combination induces synergistic antitumor effect in prostate cancer cells via concurrent inhibition of the mevalonate pathway,33032653
